| 3.9 |
11.7 |
GO:0007506 |
gonadal mesoderm development(GO:0007506) |
| 2.9 |
11.5 |
GO:0010900 |
negative regulation of phosphatidylcholine catabolic process(GO:0010900) |
| 2.5 |
7.5 |
GO:0043181 |
vacuolar sequestering(GO:0043181) |
| 2.3 |
2.3 |
GO:0036309 |
protein localization to M-band(GO:0036309) |
| 2.3 |
6.8 |
GO:0050720 |
regulation of interleukin-1 biosynthetic process(GO:0045360) positive regulation of interleukin-1 biosynthetic process(GO:0045362) interleukin-1 beta biosynthetic process(GO:0050720) |
| 2.2 |
6.6 |
GO:0021919 |
BMP signaling pathway involved in spinal cord dorsal/ventral patterning(GO:0021919) |
| 2.1 |
6.2 |
GO:0002416 |
IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor(GO:0002416) |
| 2.0 |
12.1 |
GO:0061143 |
alveolar primary septum development(GO:0061143) |
| 2.0 |
6.0 |
GO:0007037 |
vacuolar phosphate transport(GO:0007037) positive regulation of mitotic cell cycle DNA replication(GO:1903465) positive regulation of parathyroid hormone secretion(GO:2000830) |
| 2.0 |
8.0 |
GO:0002268 |
follicular dendritic cell differentiation(GO:0002268) |
| 1.9 |
5.7 |
GO:0015920 |
lipopolysaccharide transport(GO:0015920) |
| 1.9 |
5.7 |
GO:0043105 |
regulation of GTP cyclohydrolase I activity(GO:0043095) negative regulation of GTP cyclohydrolase I activity(GO:0043105) |
| 1.8 |
1.8 |
GO:0090346 |
cellular organohalogen metabolic process(GO:0090345) cellular organofluorine metabolic process(GO:0090346) |
| 1.8 |
3.6 |
GO:0060193 |
positive regulation of lipase activity(GO:0060193) |
| 1.7 |
8.4 |
GO:2000110 |
negative regulation of macrophage apoptotic process(GO:2000110) |
| 1.7 |
1.7 |
GO:0032290 |
peripheral nervous system myelin formation(GO:0032290) |
| 1.6 |
9.7 |
GO:1904274 |
tricellular tight junction assembly(GO:1904274) |
| 1.6 |
3.1 |
GO:0035419 |
activation of MAPK activity involved in innate immune response(GO:0035419) |
| 1.6 |
1.6 |
GO:0090343 |
positive regulation of cell aging(GO:0090343) positive regulation of cellular senescence(GO:2000774) |
| 1.5 |
6.2 |
GO:1902723 |
negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
| 1.5 |
10.5 |
GO:0046208 |
spermine catabolic process(GO:0046208) |
| 1.5 |
7.5 |
GO:1904844 |
response to L-glutamine(GO:1904844) cellular response to L-glutamine(GO:1904845) |
| 1.5 |
1.5 |
GO:0010726 |
positive regulation of hydrogen peroxide metabolic process(GO:0010726) |
| 1.5 |
19.2 |
GO:0043435 |
response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
| 1.4 |
7.2 |
GO:0000738 |
DNA catabolic process, exonucleolytic(GO:0000738) |
| 1.4 |
2.9 |
GO:0051532 |
regulation of NFAT protein import into nucleus(GO:0051532) positive regulation of NFAT protein import into nucleus(GO:0051533) |
| 1.4 |
7.1 |
GO:0090031 |
positive regulation of steroid hormone biosynthetic process(GO:0090031) |
| 1.4 |
4.3 |
GO:0036090 |
cleavage furrow ingression(GO:0036090) |
| 1.4 |
4.2 |
GO:0035623 |
renal glucose absorption(GO:0035623) |
| 1.4 |
6.8 |
GO:0015688 |
iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
| 1.4 |
4.1 |
GO:0071629 |
cytoplasm-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071629) |
| 1.4 |
4.1 |
GO:1903410 |
lysine import(GO:0034226) L-lysine import(GO:0061461) L-lysine import into cell(GO:1903410) |
| 1.4 |
6.8 |
GO:0009440 |
cyanate metabolic process(GO:0009439) cyanate catabolic process(GO:0009440) |
| 1.3 |
4.0 |
GO:0048210 |
Golgi vesicle fusion to target membrane(GO:0048210) |
| 1.3 |
1.3 |
GO:0090116 |
C-5 methylation of cytosine(GO:0090116) |
| 1.3 |
9.1 |
GO:0045079 |
negative regulation of chemokine biosynthetic process(GO:0045079) |
| 1.3 |
3.9 |
GO:0003245 |
cardiac muscle tissue growth involved in heart morphogenesis(GO:0003245) |
| 1.3 |
3.8 |
GO:0060927 |
Purkinje myocyte differentiation(GO:0003168) cardiac pacemaker cell fate commitment(GO:0060927) atrioventricular node cell fate commitment(GO:0060929) |
| 1.3 |
1.3 |
GO:1903800 |
positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
| 1.3 |
5.1 |
GO:0021966 |
corticospinal neuron axon guidance(GO:0021966) |
| 1.3 |
6.4 |
GO:0071409 |
cellular response to cycloheximide(GO:0071409) |
| 1.3 |
6.3 |
GO:0048807 |
female genitalia morphogenesis(GO:0048807) |
| 1.2 |
6.2 |
GO:0098502 |
DNA dephosphorylation(GO:0098502) |
| 1.2 |
3.7 |
GO:0099558 |
maintenance of synapse structure(GO:0099558) |
| 1.2 |
1.2 |
GO:2001184 |
positive regulation of interleukin-12 secretion(GO:2001184) |
| 1.2 |
3.6 |
GO:0061181 |
regulation of chondrocyte development(GO:0061181) |
| 1.2 |
4.8 |
GO:1904106 |
protein localization to microvillus(GO:1904106) |
| 1.2 |
4.7 |
GO:0072061 |
inner medullary collecting duct development(GO:0072061) |
| 1.2 |
3.5 |
GO:0010898 |
positive regulation of triglyceride catabolic process(GO:0010898) |
| 1.2 |
6.9 |
GO:0009181 |
purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
| 1.1 |
5.7 |
GO:0032218 |
riboflavin transport(GO:0032218) |
| 1.1 |
3.4 |
GO:0019243 |
methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
| 1.1 |
3.3 |
GO:0002731 |
negative regulation of dendritic cell cytokine production(GO:0002731) |
| 1.1 |
3.3 |
GO:0060278 |
regulation of ovulation(GO:0060278) positive regulation of ovulation(GO:0060279) |
| 1.1 |
6.5 |
GO:1902499 |
positive regulation of protein autoubiquitination(GO:1902499) |
| 1.1 |
3.2 |
GO:0035359 |
negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
| 1.1 |
3.2 |
GO:0090427 |
activation of meiosis(GO:0090427) |
| 1.1 |
4.2 |
GO:0000294 |
nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay(GO:0000294) |
| 1.1 |
6.3 |
GO:0019418 |
sulfide oxidation(GO:0019418) sulfide oxidation, using sulfide:quinone oxidoreductase(GO:0070221) |
| 1.0 |
9.4 |
GO:0046618 |
drug export(GO:0046618) |
| 1.0 |
3.1 |
GO:1904247 |
positive regulation of polynucleotide adenylyltransferase activity(GO:1904247) |
| 1.0 |
6.2 |
GO:0009051 |
pentose-phosphate shunt, oxidative branch(GO:0009051) |
| 1.0 |
3.1 |
GO:0035284 |
rhombomere 5 development(GO:0021571) central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
| 1.0 |
2.0 |
GO:0009794 |
regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
| 1.0 |
4.1 |
GO:0060856 |
establishment of blood-brain barrier(GO:0060856) |
| 1.0 |
3.0 |
GO:0006258 |
UDP-glucose catabolic process(GO:0006258) |
| 1.0 |
7.0 |
GO:0010133 |
proline catabolic process to glutamate(GO:0010133) |
| 1.0 |
3.0 |
GO:1903926 |
signal transduction involved in intra-S DNA damage checkpoint(GO:0072428) response to bisphenol A(GO:1903925) cellular response to bisphenol A(GO:1903926) |
| 1.0 |
4.9 |
GO:0038018 |
Wnt receptor catabolic process(GO:0038018) |
| 1.0 |
3.0 |
GO:1901207 |
regulation of heart looping(GO:1901207) |
| 1.0 |
3.0 |
GO:0060796 |
regulation of transcription involved in primary germ layer cell fate commitment(GO:0060796) |
| 1.0 |
4.9 |
GO:0071051 |
polyadenylation-dependent snoRNA 3'-end processing(GO:0071051) |
| 1.0 |
3.9 |
GO:0034444 |
regulation of plasma lipoprotein particle oxidation(GO:0034444) negative regulation of plasma lipoprotein particle oxidation(GO:0034445) |
| 1.0 |
3.9 |
GO:0032811 |
regulation of epinephrine secretion(GO:0014060) negative regulation of epinephrine secretion(GO:0032811) epinephrine secretion(GO:0048242) |
| 1.0 |
2.9 |
GO:0060722 |
spongiotrophoblast cell proliferation(GO:0060720) regulation of spongiotrophoblast cell proliferation(GO:0060721) cell proliferation involved in embryonic placenta development(GO:0060722) regulation of cell proliferation involved in embryonic placenta development(GO:0060723) |
| 1.0 |
2.9 |
GO:0001994 |
norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
| 1.0 |
3.8 |
GO:0032286 |
central nervous system myelin maintenance(GO:0032286) |
| 0.9 |
1.9 |
GO:0015911 |
plasma membrane long-chain fatty acid transport(GO:0015911) |
| 0.9 |
4.7 |
GO:0009996 |
negative regulation of cell fate specification(GO:0009996) |
| 0.9 |
4.7 |
GO:0060160 |
negative regulation of dopamine receptor signaling pathway(GO:0060160) |
| 0.9 |
6.6 |
GO:2000857 |
positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
| 0.9 |
2.8 |
GO:0016561 |
protein import into peroxisome matrix, translocation(GO:0016561) |
| 0.9 |
9.2 |
GO:0042997 |
negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
| 0.9 |
2.7 |
GO:0010621 |
negative regulation of transcription by transcription factor localization(GO:0010621) |
| 0.9 |
0.9 |
GO:0002582 |
positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) positive regulation of antigen processing and presentation of peptide antigen(GO:0002585) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) |
| 0.9 |
5.4 |
GO:1902462 |
regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
| 0.9 |
2.7 |
GO:0015680 |
intracellular copper ion transport(GO:0015680) |
| 0.9 |
5.4 |
GO:0015722 |
canalicular bile acid transport(GO:0015722) |
| 0.9 |
2.7 |
GO:0090274 |
regulation of somatostatin secretion(GO:0090273) positive regulation of somatostatin secretion(GO:0090274) |
| 0.9 |
8.9 |
GO:0097039 |
protein linear polyubiquitination(GO:0097039) |
| 0.9 |
0.9 |
GO:1904393 |
regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904393) negative regulation of neuromuscular junction development(GO:1904397) |
| 0.9 |
3.6 |
GO:0006850 |
mitochondrial pyruvate transport(GO:0006850) mitochondrial pyruvate transmembrane transport(GO:1902361) |
| 0.9 |
7.1 |
GO:0032417 |
positive regulation of sodium:proton antiporter activity(GO:0032417) |
| 0.9 |
2.7 |
GO:0035606 |
peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
| 0.9 |
13.3 |
GO:0032049 |
cardiolipin biosynthetic process(GO:0032049) |
| 0.9 |
2.7 |
GO:2001226 |
negative regulation of chloride transport(GO:2001226) |
| 0.9 |
5.2 |
GO:0035865 |
cellular response to potassium ion(GO:0035865) |
| 0.9 |
3.5 |
GO:1902683 |
regulation of receptor localization to synapse(GO:1902683) |
| 0.9 |
13.7 |
GO:0000050 |
urea cycle(GO:0000050) |
| 0.8 |
1.7 |
GO:0045907 |
positive regulation of vasoconstriction(GO:0045907) |
| 0.8 |
14.8 |
GO:1901750 |
leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
| 0.8 |
0.8 |
GO:0048320 |
axial mesoderm formation(GO:0048320) |
| 0.8 |
2.4 |
GO:0070407 |
oxidation-dependent protein catabolic process(GO:0070407) |
| 0.8 |
2.4 |
GO:0072156 |
distal tubule morphogenesis(GO:0072156) |
| 0.8 |
2.4 |
GO:0097195 |
pilomotor reflex(GO:0097195) |
| 0.8 |
2.4 |
GO:0009443 |
pyridoxal 5'-phosphate salvage(GO:0009443) |
| 0.8 |
3.2 |
GO:2001178 |
mediator complex assembly(GO:0036034) regulation of mediator complex assembly(GO:2001176) positive regulation of mediator complex assembly(GO:2001178) |
| 0.8 |
6.4 |
GO:0097461 |
ferric iron import into cell(GO:0097461) ferric iron import across plasma membrane(GO:0098706) |
| 0.8 |
1.6 |
GO:0019520 |
aldonic acid metabolic process(GO:0019520) D-gluconate metabolic process(GO:0019521) |
| 0.8 |
1.6 |
GO:0035407 |
histone H3-T11 phosphorylation(GO:0035407) |
| 0.8 |
6.3 |
GO:0060136 |
embryonic process involved in female pregnancy(GO:0060136) |
| 0.8 |
1.6 |
GO:0006751 |
glutathione catabolic process(GO:0006751) |
| 0.8 |
5.5 |
GO:0015793 |
glycerol transport(GO:0015793) |
| 0.8 |
1.6 |
GO:0090071 |
negative regulation of ribosome biogenesis(GO:0090071) |
| 0.8 |
2.3 |
GO:0060061 |
Spemann organizer formation(GO:0060061) |
| 0.8 |
2.3 |
GO:0035063 |
nuclear speck organization(GO:0035063) |
| 0.8 |
2.3 |
GO:0046080 |
dUTP metabolic process(GO:0046080) dUTP catabolic process(GO:0046081) |
| 0.8 |
2.3 |
GO:0052510 |
induction by symbiont of host defense response(GO:0044416) induction of host immune response by virus(GO:0046730) active induction of host immune response by virus(GO:0046732) modulation by symbiont of host defense response(GO:0052031) induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) modulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052255) positive regulation by symbiont of host defense response(GO:0052509) positive regulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052510) modulation by organism of immune response of other organism involved in symbiotic interaction(GO:0052552) modulation by symbiont of host immune response(GO:0052553) modulation by virus of host immune response(GO:0075528) |
| 0.8 |
2.3 |
GO:1901076 |
positive regulation of engulfment of apoptotic cell(GO:1901076) |
| 0.8 |
6.9 |
GO:0006701 |
progesterone biosynthetic process(GO:0006701) |
| 0.8 |
3.8 |
GO:0000430 |
regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) |
| 0.8 |
7.6 |
GO:2000210 |
positive regulation of anoikis(GO:2000210) |
| 0.8 |
2.3 |
GO:0060265 |
positive regulation of respiratory burst involved in inflammatory response(GO:0060265) |
| 0.8 |
9.8 |
GO:0019375 |
galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
| 0.8 |
6.8 |
GO:0060754 |
positive regulation of mast cell chemotaxis(GO:0060754) |
| 0.7 |
9.7 |
GO:0090261 |
positive regulation of inclusion body assembly(GO:0090261) |
| 0.7 |
4.5 |
GO:0043126 |
regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043126) positive regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043128) |
| 0.7 |
1.5 |
GO:0043585 |
nose morphogenesis(GO:0043585) |
| 0.7 |
0.7 |
GO:0060584 |
regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
| 0.7 |
0.7 |
GO:2000721 |
positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
| 0.7 |
2.2 |
GO:0061394 |
regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance(GO:0061394) |
| 0.7 |
4.4 |
GO:0072218 |
ascending thin limb development(GO:0072021) metanephric ascending thin limb development(GO:0072218) metanephric loop of Henle development(GO:0072236) |
| 0.7 |
2.2 |
GO:1990697 |
protein depalmitoleylation(GO:1990697) |
| 0.7 |
1.4 |
GO:1902174 |
positive regulation of keratinocyte apoptotic process(GO:1902174) |
| 0.7 |
0.7 |
GO:0070555 |
response to interleukin-1(GO:0070555) |
| 0.7 |
2.8 |
GO:0042369 |
vitamin D catabolic process(GO:0042369) |
| 0.7 |
2.1 |
GO:0097187 |
dentinogenesis(GO:0097187) |
| 0.7 |
2.1 |
GO:0017186 |
peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase(GO:0017186) |
| 0.7 |
1.4 |
GO:1904469 |
positive regulation of tumor necrosis factor secretion(GO:1904469) |
| 0.7 |
2.7 |
GO:0050766 |
positive regulation of phagocytosis(GO:0050766) |
| 0.7 |
0.7 |
GO:0099504 |
synaptic vesicle cycle(GO:0099504) |
| 0.7 |
2.0 |
GO:0021938 |
ventral midline development(GO:0007418) smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) notochord regression(GO:0060032) |
| 0.7 |
2.0 |
GO:0034553 |
respiratory chain complex II assembly(GO:0034552) mitochondrial respiratory chain complex II assembly(GO:0034553) mitochondrial respiratory chain complex II biogenesis(GO:0097032) |
| 0.7 |
0.7 |
GO:1902022 |
lysine transport(GO:0015819) L-lysine transport(GO:1902022) L-lysine transmembrane transport(GO:1903401) |
| 0.7 |
6.0 |
GO:0018094 |
protein polyglycylation(GO:0018094) |
| 0.7 |
2.0 |
GO:0001798 |
positive regulation of type IIa hypersensitivity(GO:0001798) positive regulation of type II hypersensitivity(GO:0002894) |
| 0.7 |
2.0 |
GO:0007228 |
positive regulation of hh target transcription factor activity(GO:0007228) |
| 0.7 |
3.9 |
GO:0015822 |
ornithine transport(GO:0015822) |
| 0.7 |
0.7 |
GO:1903223 |
positive regulation of oxidative stress-induced neuron death(GO:1903223) positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
| 0.7 |
1.3 |
GO:0031630 |
regulation of synaptic vesicle fusion to presynaptic membrane(GO:0031630) |
| 0.7 |
3.3 |
GO:0003357 |
noradrenergic neuron differentiation(GO:0003357) |
| 0.6 |
5.8 |
GO:0001661 |
conditioned taste aversion(GO:0001661) |
| 0.6 |
5.2 |
GO:0071321 |
cellular response to cGMP(GO:0071321) |
| 0.6 |
3.2 |
GO:0060741 |
prostate gland stromal morphogenesis(GO:0060741) |
| 0.6 |
1.9 |
GO:2000824 |
negative regulation of androgen receptor activity(GO:2000824) |
| 0.6 |
3.2 |
GO:0042412 |
taurine biosynthetic process(GO:0042412) |
| 0.6 |
5.7 |
GO:0031444 |
slow-twitch skeletal muscle fiber contraction(GO:0031444) |
| 0.6 |
2.5 |
GO:0044240 |
multicellular organism lipid catabolic process(GO:0044240) |
| 0.6 |
3.1 |
GO:0008588 |
release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
| 0.6 |
1.8 |
GO:1901873 |
regulation of post-translational protein modification(GO:1901873) |
| 0.6 |
2.5 |
GO:1904398 |
positive regulation of neuromuscular junction development(GO:1904398) |
| 0.6 |
2.4 |
GO:1901491 |
negative regulation of lymphangiogenesis(GO:1901491) |
| 0.6 |
1.2 |
GO:1902512 |
positive regulation of apoptotic DNA fragmentation(GO:1902512) |
| 0.6 |
1.8 |
GO:1904603 |
regulation of connective tissue replacement involved in inflammatory response wound healing(GO:1904596) negative regulation of connective tissue replacement involved in inflammatory response wound healing(GO:1904597) regulation of advanced glycation end-product receptor activity(GO:1904603) negative regulation of advanced glycation end-product receptor activity(GO:1904604) negative regulation of connective tissue replacement(GO:1905204) |
| 0.6 |
2.4 |
GO:0071318 |
cellular response to ATP(GO:0071318) |
| 0.6 |
2.4 |
GO:1903939 |
regulation of TORC2 signaling(GO:1903939) |
| 0.6 |
3.0 |
GO:0034224 |
cellular response to zinc ion starvation(GO:0034224) |
| 0.6 |
1.8 |
GO:2000502 |
negative regulation of natural killer cell chemotaxis(GO:2000502) |
| 0.6 |
1.2 |
GO:0060022 |
hard palate development(GO:0060022) |
| 0.6 |
2.4 |
GO:0033299 |
secretion of lysosomal enzymes(GO:0033299) |
| 0.6 |
1.2 |
GO:0036515 |
serotonergic neuron axon guidance(GO:0036515) |
| 0.6 |
0.6 |
GO:0017055 |
negative regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0017055) |
| 0.6 |
2.4 |
GO:1903949 |
positive regulation of atrial cardiac muscle cell action potential(GO:1903949) |
| 0.6 |
0.6 |
GO:0042376 |
phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
| 0.6 |
2.4 |
GO:0072344 |
rescue of stalled ribosome(GO:0072344) |
| 0.6 |
3.0 |
GO:1903412 |
response to bile acid(GO:1903412) |
| 0.6 |
1.8 |
GO:0042137 |
sequestering of neurotransmitter(GO:0042137) |
| 0.6 |
1.8 |
GO:0051562 |
negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
| 0.6 |
0.6 |
GO:0072268 |
pattern specification involved in metanephros development(GO:0072268) |
| 0.6 |
1.8 |
GO:1903526 |
negative regulation of membrane tubulation(GO:1903526) |
| 0.6 |
3.5 |
GO:1903300 |
negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
| 0.6 |
2.3 |
GO:2000418 |
positive regulation of eosinophil migration(GO:2000418) |
| 0.6 |
1.8 |
GO:2000349 |
regulation of toll-like receptor 5 signaling pathway(GO:0034147) negative regulation of toll-like receptor 5 signaling pathway(GO:0034148) negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070429) tolerance induction to lipopolysaccharide(GO:0072573) negative regulation of CD40 signaling pathway(GO:2000349) |
| 0.6 |
5.8 |
GO:0051902 |
negative regulation of mitochondrial depolarization(GO:0051902) |
| 0.6 |
0.6 |
GO:0035811 |
negative regulation of urine volume(GO:0035811) |
| 0.6 |
2.9 |
GO:0035519 |
protein K29-linked ubiquitination(GO:0035519) |
| 0.6 |
10.8 |
GO:0051006 |
positive regulation of lipoprotein lipase activity(GO:0051006) |
| 0.6 |
5.7 |
GO:0002480 |
antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
| 0.6 |
2.8 |
GO:0097029 |
mature conventional dendritic cell differentiation(GO:0097029) |
| 0.6 |
1.7 |
GO:0052330 |
induction of programmed cell death(GO:0012502) positive regulation of apoptotic process in other organism(GO:0044533) positive regulation by symbiont of host programmed cell death(GO:0052042) positive regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052330) positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction(GO:0052501) |
| 0.6 |
0.6 |
GO:0060629 |
regulation of homologous chromosome segregation(GO:0060629) |
| 0.6 |
3.4 |
GO:0051673 |
membrane disruption in other organism(GO:0051673) |
| 0.6 |
2.2 |
GO:0052026 |
modulation by virus of host transcription(GO:0019056) positive regulation of sprouting of injured axon(GO:0048687) positive regulation of axon extension involved in regeneration(GO:0048691) modulation by symbiont of host transcription(GO:0052026) |
| 0.6 |
3.9 |
GO:0033159 |
negative regulation of protein import into nucleus, translocation(GO:0033159) |
| 0.6 |
5.6 |
GO:0010454 |
negative regulation of cell fate commitment(GO:0010454) |
| 0.5 |
2.2 |
GO:0030920 |
N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
| 0.5 |
1.6 |
GO:0021526 |
medial motor column neuron differentiation(GO:0021526) |
| 0.5 |
1.6 |
GO:0006522 |
alanine metabolic process(GO:0006522) alanine catabolic process(GO:0006524) pyruvate family amino acid metabolic process(GO:0009078) pyruvate family amino acid catabolic process(GO:0009080) |
| 0.5 |
0.5 |
GO:0030224 |
monocyte differentiation(GO:0030224) |
| 0.5 |
1.6 |
GO:0036289 |
peptidyl-serine autophosphorylation(GO:0036289) |
| 0.5 |
1.1 |
GO:0046320 |
regulation of fatty acid oxidation(GO:0046320) |
| 0.5 |
0.5 |
GO:0009447 |
putrescine catabolic process(GO:0009447) polyamine acetylation(GO:0032917) spermidine acetylation(GO:0032918) |
| 0.5 |
2.1 |
GO:0010040 |
response to iron(II) ion(GO:0010040) |
| 0.5 |
0.5 |
GO:0002052 |
positive regulation of neuroblast proliferation(GO:0002052) |
| 0.5 |
5.3 |
GO:0045218 |
zonula adherens maintenance(GO:0045218) |
| 0.5 |
3.2 |
GO:0030644 |
cellular chloride ion homeostasis(GO:0030644) |
| 0.5 |
2.1 |
GO:0035425 |
autocrine signaling(GO:0035425) |
| 0.5 |
1.6 |
GO:1990523 |
bone regeneration(GO:1990523) |
| 0.5 |
3.7 |
GO:0006102 |
isocitrate metabolic process(GO:0006102) |
| 0.5 |
0.5 |
GO:0071888 |
macrophage apoptotic process(GO:0071888) |
| 0.5 |
2.6 |
GO:1902474 |
positive regulation of protein localization to synapse(GO:1902474) |
| 0.5 |
1.6 |
GO:0015993 |
molecular hydrogen transport(GO:0015993) |
| 0.5 |
2.1 |
GO:0060024 |
rhythmic synaptic transmission(GO:0060024) |
| 0.5 |
2.1 |
GO:0015985 |
energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
| 0.5 |
3.1 |
GO:0035990 |
tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
| 0.5 |
3.5 |
GO:0009189 |
deoxyribonucleoside diphosphate biosynthetic process(GO:0009189) |
| 0.5 |
1.5 |
GO:0048250 |
mitochondrial iron ion transport(GO:0048250) |
| 0.5 |
2.0 |
GO:0090289 |
regulation of osteoclast proliferation(GO:0090289) |
| 0.5 |
2.0 |
GO:0070843 |
misfolded protein transport(GO:0070843) polyubiquitinated protein transport(GO:0070844) polyubiquitinated misfolded protein transport(GO:0070845) Hsp90 deacetylation(GO:0070846) |
| 0.5 |
0.5 |
GO:0071500 |
cellular response to nitrosative stress(GO:0071500) |
| 0.5 |
4.0 |
GO:0043117 |
positive regulation of vascular permeability(GO:0043117) |
| 0.5 |
1.5 |
GO:0060086 |
circadian temperature homeostasis(GO:0060086) |
| 0.5 |
2.0 |
GO:0046462 |
monoacylglycerol metabolic process(GO:0046462) monoacylglycerol catabolic process(GO:0052651) |
| 0.5 |
1.5 |
GO:0035674 |
tricarboxylic acid transmembrane transport(GO:0035674) |
| 0.5 |
1.5 |
GO:0038162 |
erythropoietin-mediated signaling pathway(GO:0038162) |
| 0.5 |
1.5 |
GO:0019516 |
lactate oxidation(GO:0019516) |
| 0.5 |
10.9 |
GO:0048172 |
regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.5 |
1.0 |
GO:0048311 |
mitochondrion distribution(GO:0048311) |
| 0.5 |
0.5 |
GO:0021569 |
rhombomere 3 development(GO:0021569) |
| 0.5 |
1.5 |
GO:0090272 |
negative regulation of fibroblast growth factor production(GO:0090272) |
| 0.5 |
6.9 |
GO:0006228 |
UTP biosynthetic process(GO:0006228) |
| 0.5 |
1.5 |
GO:0044209 |
AMP salvage(GO:0044209) |
| 0.5 |
1.5 |
GO:0009133 |
nucleoside diphosphate biosynthetic process(GO:0009133) |
| 0.5 |
1.5 |
GO:0021546 |
rhombomere development(GO:0021546) |
| 0.5 |
1.0 |
GO:1902563 |
regulation of neutrophil degranulation(GO:0043313) regulation of neutrophil activation(GO:1902563) |
| 0.5 |
1.0 |
GO:0097531 |
mast cell migration(GO:0097531) |
| 0.5 |
5.3 |
GO:0098795 |
mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
| 0.5 |
1.4 |
GO:0071930 |
negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
| 0.5 |
1.4 |
GO:0035137 |
hindlimb morphogenesis(GO:0035137) |
| 0.5 |
1.4 |
GO:1900738 |
positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
| 0.5 |
0.5 |
GO:1904479 |
negative regulation of intestinal absorption(GO:1904479) |
| 0.5 |
7.6 |
GO:0005984 |
disaccharide metabolic process(GO:0005984) |
| 0.5 |
2.4 |
GO:0016185 |
synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) |
| 0.5 |
1.9 |
GO:0022007 |
neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
| 0.5 |
1.9 |
GO:0046967 |
cytosol to ER transport(GO:0046967) |
| 0.5 |
2.8 |
GO:0060426 |
lung vasculature development(GO:0060426) |
| 0.5 |
1.4 |
GO:0042631 |
cellular response to water deprivation(GO:0042631) |
| 0.5 |
4.2 |
GO:0032226 |
positive regulation of synaptic transmission, dopaminergic(GO:0032226) |
| 0.5 |
1.9 |
GO:0000103 |
sulfate assimilation(GO:0000103) |
| 0.5 |
0.5 |
GO:0098700 |
neurotransmitter loading into synaptic vesicle(GO:0098700) |
| 0.5 |
1.4 |
GO:1902630 |
regulation of membrane hyperpolarization(GO:1902630) |
| 0.5 |
2.3 |
GO:0032571 |
response to vitamin K(GO:0032571) |
| 0.5 |
1.4 |
GO:1901842 |
negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
| 0.5 |
0.5 |
GO:0035038 |
female pronucleus assembly(GO:0035038) |
| 0.5 |
0.9 |
GO:0007412 |
axon target recognition(GO:0007412) |
| 0.5 |
1.8 |
GO:0043456 |
regulation of pentose-phosphate shunt(GO:0043456) |
| 0.5 |
2.3 |
GO:0090202 |
transcriptional activation by promoter-enhancer looping(GO:0071733) gene looping(GO:0090202) dsDNA loop formation(GO:0090579) |
| 0.5 |
2.3 |
GO:0010807 |
regulation of synaptic vesicle priming(GO:0010807) |
| 0.5 |
2.7 |
GO:0060263 |
regulation of respiratory burst(GO:0060263) |
| 0.4 |
1.8 |
GO:1990403 |
embryonic brain development(GO:1990403) |
| 0.4 |
0.9 |
GO:0021849 |
neuroblast division in subventricular zone(GO:0021849) |
| 0.4 |
1.3 |
GO:0051823 |
regulation of synapse structural plasticity(GO:0051823) |
| 0.4 |
2.2 |
GO:0051970 |
negative regulation of transmission of nerve impulse(GO:0051970) |
| 0.4 |
1.8 |
GO:1905224 |
clathrin-coated pit assembly(GO:1905224) |
| 0.4 |
0.9 |
GO:0019322 |
pentose biosynthetic process(GO:0019322) |
| 0.4 |
5.6 |
GO:0035826 |
rubidium ion transport(GO:0035826) regulation of rubidium ion transport(GO:2000680) |
| 0.4 |
0.4 |
GO:0071421 |
manganese ion transmembrane transport(GO:0071421) |
| 0.4 |
5.6 |
GO:0018095 |
protein polyglutamylation(GO:0018095) |
| 0.4 |
4.3 |
GO:0071569 |
protein ufmylation(GO:0071569) |
| 0.4 |
1.3 |
GO:1900075 |
regulation of neuromuscular synaptic transmission(GO:1900073) positive regulation of neuromuscular synaptic transmission(GO:1900075) |
| 0.4 |
5.1 |
GO:0070327 |
thyroid hormone transport(GO:0070327) |
| 0.4 |
0.8 |
GO:0014850 |
response to muscle activity(GO:0014850) |
| 0.4 |
7.6 |
GO:0051152 |
positive regulation of smooth muscle cell differentiation(GO:0051152) |
| 0.4 |
0.8 |
GO:0031125 |
rRNA 3'-end processing(GO:0031125) |
| 0.4 |
1.3 |
GO:0071586 |
CAAX-box protein processing(GO:0071586) CAAX-box protein maturation(GO:0080120) |
| 0.4 |
2.5 |
GO:1900220 |
semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
| 0.4 |
2.1 |
GO:0036018 |
response to erythropoietin(GO:0036017) cellular response to erythropoietin(GO:0036018) |
| 0.4 |
0.4 |
GO:0072194 |
kidney smooth muscle tissue development(GO:0072194) |
| 0.4 |
2.9 |
GO:0010609 |
mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) |
| 0.4 |
4.9 |
GO:0009757 |
hexose mediated signaling(GO:0009757) sugar mediated signaling pathway(GO:0010182) glucose mediated signaling pathway(GO:0010255) |
| 0.4 |
0.8 |
GO:0061073 |
ciliary body morphogenesis(GO:0061073) |
| 0.4 |
2.5 |
GO:0030421 |
defecation(GO:0030421) |
| 0.4 |
1.6 |
GO:0035864 |
response to potassium ion(GO:0035864) |
| 0.4 |
12.3 |
GO:0046597 |
negative regulation of viral entry into host cell(GO:0046597) |
| 0.4 |
1.2 |
GO:1990922 |
regulation of hepatic stellate cell proliferation(GO:1904897) positive regulation of hepatic stellate cell proliferation(GO:1904899) hepatic stellate cell proliferation(GO:1990922) |
| 0.4 |
3.2 |
GO:0048295 |
positive regulation of isotype switching to IgE isotypes(GO:0048295) |
| 0.4 |
0.8 |
GO:0019852 |
L-ascorbic acid metabolic process(GO:0019852) |
| 0.4 |
3.2 |
GO:0006880 |
intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
| 0.4 |
1.2 |
GO:0070676 |
intralumenal vesicle formation(GO:0070676) |
| 0.4 |
8.7 |
GO:0000028 |
ribosomal small subunit assembly(GO:0000028) |
| 0.4 |
0.4 |
GO:0032707 |
negative regulation of interleukin-23 production(GO:0032707) |
| 0.4 |
2.0 |
GO:0030222 |
eosinophil differentiation(GO:0030222) |
| 0.4 |
3.9 |
GO:0045039 |
protein import into mitochondrial inner membrane(GO:0045039) |
| 0.4 |
0.4 |
GO:0060164 |
regulation of timing of neuron differentiation(GO:0060164) |
| 0.4 |
0.4 |
GO:0061357 |
positive regulation of Wnt protein secretion(GO:0061357) |
| 0.4 |
13.5 |
GO:0042776 |
mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
| 0.4 |
1.9 |
GO:0030382 |
sperm mitochondrion organization(GO:0030382) |
| 0.4 |
1.2 |
GO:1900222 |
negative regulation of beta-amyloid clearance(GO:1900222) |
| 0.4 |
0.4 |
GO:0002880 |
chronic inflammatory response to non-antigenic stimulus(GO:0002545) regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002880) |
| 0.4 |
2.3 |
GO:0061744 |
motor behavior(GO:0061744) |
| 0.4 |
1.9 |
GO:0046898 |
response to cycloheximide(GO:0046898) |
| 0.4 |
1.1 |
GO:1904924 |
negative regulation of mitophagy in response to mitochondrial depolarization(GO:1904924) |
| 0.4 |
2.3 |
GO:0015015 |
heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 0.4 |
0.4 |
GO:0045082 |
positive regulation of interleukin-10 biosynthetic process(GO:0045082) |
| 0.4 |
4.6 |
GO:0023041 |
neuronal signal transduction(GO:0023041) |
| 0.4 |
1.5 |
GO:0003335 |
corneocyte development(GO:0003335) |
| 0.4 |
0.8 |
GO:0031508 |
pericentric heterochromatin assembly(GO:0031508) |
| 0.4 |
0.8 |
GO:0036146 |
cellular response to mycotoxin(GO:0036146) |
| 0.4 |
3.0 |
GO:0086046 |
membrane depolarization during SA node cell action potential(GO:0086046) |
| 0.4 |
1.5 |
GO:0071672 |
negative regulation of smooth muscle cell chemotaxis(GO:0071672) |
| 0.4 |
2.6 |
GO:1901569 |
leukotriene catabolic process(GO:0036100) leukotriene B4 catabolic process(GO:0036101) leukotriene B4 metabolic process(GO:0036102) icosanoid catabolic process(GO:1901523) fatty acid derivative catabolic process(GO:1901569) |
| 0.4 |
4.5 |
GO:0007042 |
lysosomal lumen acidification(GO:0007042) |
| 0.4 |
7.8 |
GO:0019336 |
phenol-containing compound catabolic process(GO:0019336) |
| 0.4 |
1.5 |
GO:1904059 |
regulation of locomotor rhythm(GO:1904059) |
| 0.4 |
1.8 |
GO:0070427 |
nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
| 0.4 |
1.8 |
GO:0061737 |
leukotriene signaling pathway(GO:0061737) |
| 0.4 |
1.8 |
GO:0050915 |
sensory perception of sour taste(GO:0050915) |
| 0.4 |
0.7 |
GO:0034165 |
positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
| 0.4 |
0.4 |
GO:0043686 |
co-translational protein modification(GO:0043686) |
| 0.4 |
2.6 |
GO:0044878 |
mitotic cytokinesis checkpoint(GO:0044878) |
| 0.4 |
0.4 |
GO:0009756 |
carbohydrate mediated signaling(GO:0009756) |
| 0.4 |
0.7 |
GO:1902949 |
positive regulation of tau-protein kinase activity(GO:1902949) |
| 0.4 |
9.5 |
GO:0031167 |
rRNA methylation(GO:0031167) |
| 0.4 |
5.1 |
GO:0048251 |
elastic fiber assembly(GO:0048251) |
| 0.4 |
4.3 |
GO:0051601 |
exocyst localization(GO:0051601) |
| 0.4 |
0.4 |
GO:0045349 |
interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) |
| 0.4 |
2.9 |
GO:0035610 |
protein side chain deglutamylation(GO:0035610) |
| 0.4 |
2.2 |
GO:0031017 |
exocrine pancreas development(GO:0031017) |
| 0.4 |
1.4 |
GO:0002949 |
tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 0.4 |
1.1 |
GO:0043318 |
negative regulation of response to tumor cell(GO:0002835) negative regulation of immune response to tumor cell(GO:0002838) negative regulation of natural killer cell mediated immune response to tumor cell(GO:0002856) negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002859) regulation of cytotoxic T cell degranulation(GO:0043317) negative regulation of cytotoxic T cell degranulation(GO:0043318) |
| 0.4 |
1.8 |
GO:0014057 |
positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) |
| 0.4 |
2.1 |
GO:0021539 |
subthalamus development(GO:0021539) |
| 0.4 |
1.4 |
GO:0003150 |
muscular septum morphogenesis(GO:0003150) |
| 0.4 |
2.5 |
GO:1900383 |
regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
| 0.4 |
2.1 |
GO:0048539 |
bone marrow development(GO:0048539) |
| 0.4 |
0.4 |
GO:0060788 |
ectodermal placode formation(GO:0060788) hair follicle placode formation(GO:0060789) ectodermal placode morphogenesis(GO:0071697) |
| 0.4 |
3.2 |
GO:0035469 |
determination of pancreatic left/right asymmetry(GO:0035469) determination of liver left/right asymmetry(GO:0071910) |
| 0.4 |
1.1 |
GO:0031548 |
regulation of brain-derived neurotrophic factor receptor signaling pathway(GO:0031548) |
| 0.4 |
2.8 |
GO:0021520 |
spinal cord motor neuron cell fate specification(GO:0021520) |
| 0.4 |
0.7 |
GO:0035262 |
gonad morphogenesis(GO:0035262) |
| 0.4 |
2.5 |
GO:0006750 |
glutathione biosynthetic process(GO:0006750) |
| 0.4 |
1.1 |
GO:0050760 |
negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
| 0.4 |
4.2 |
GO:0046498 |
S-adenosylhomocysteine metabolic process(GO:0046498) |
| 0.4 |
8.4 |
GO:0006346 |
methylation-dependent chromatin silencing(GO:0006346) |
| 0.3 |
2.1 |
GO:0019427 |
acetate biosynthetic process(GO:0019413) acetyl-CoA biosynthetic process from acetate(GO:0019427) propionate metabolic process(GO:0019541) propionate biosynthetic process(GO:0019542) |
| 0.3 |
1.0 |
GO:1903697 |
negative regulation of microvillus assembly(GO:1903697) |
| 0.3 |
0.7 |
GO:0072034 |
renal vesicle induction(GO:0072034) |
| 0.3 |
1.0 |
GO:0070634 |
transepithelial ammonium transport(GO:0070634) |
| 0.3 |
7.0 |
GO:0032780 |
negative regulation of ATPase activity(GO:0032780) |
| 0.3 |
3.5 |
GO:0014012 |
peripheral nervous system axon regeneration(GO:0014012) |
| 0.3 |
4.5 |
GO:0032364 |
oxygen homeostasis(GO:0032364) |
| 0.3 |
2.4 |
GO:0045819 |
positive regulation of glycogen catabolic process(GO:0045819) |
| 0.3 |
2.8 |
GO:0045007 |
depurination(GO:0045007) |
| 0.3 |
3.8 |
GO:2000427 |
positive regulation of apoptotic cell clearance(GO:2000427) |
| 0.3 |
5.5 |
GO:0036148 |
phosphatidylglycerol acyl-chain remodeling(GO:0036148) |
| 0.3 |
3.4 |
GO:0006002 |
fructose 6-phosphate metabolic process(GO:0006002) |
| 0.3 |
1.0 |
GO:0060392 |
negative regulation of SMAD protein import into nucleus(GO:0060392) |
| 0.3 |
0.7 |
GO:0061141 |
lung ciliated cell differentiation(GO:0061141) |
| 0.3 |
1.0 |
GO:0061580 |
colon epithelial cell migration(GO:0061580) |
| 0.3 |
2.0 |
GO:0061188 |
negative regulation of chromatin silencing at rDNA(GO:0061188) |
| 0.3 |
1.0 |
GO:0032581 |
ER-dependent peroxisome organization(GO:0032581) |
| 0.3 |
2.4 |
GO:1904154 |
positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
| 0.3 |
0.3 |
GO:0090164 |
asymmetric Golgi ribbon formation(GO:0090164) |
| 0.3 |
1.0 |
GO:0021502 |
neural fold elevation formation(GO:0021502) allantois development(GO:1905069) |
| 0.3 |
7.1 |
GO:0044342 |
type B pancreatic cell proliferation(GO:0044342) |
| 0.3 |
2.0 |
GO:0019747 |
regulation of isoprenoid metabolic process(GO:0019747) |
| 0.3 |
0.3 |
GO:0070245 |
positive regulation of thymocyte apoptotic process(GO:0070245) |
| 0.3 |
1.3 |
GO:0002143 |
tRNA wobble position uridine thiolation(GO:0002143) |
| 0.3 |
1.0 |
GO:2001033 |
negative regulation of double-strand break repair via nonhomologous end joining(GO:2001033) |
| 0.3 |
1.3 |
GO:0010918 |
positive regulation of mitochondrial membrane potential(GO:0010918) |
| 0.3 |
1.0 |
GO:0019287 |
isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
| 0.3 |
0.7 |
GO:0072205 |
metanephric collecting duct development(GO:0072205) |
| 0.3 |
1.3 |
GO:0010585 |
glutamine secretion(GO:0010585) L-glutamine import(GO:0036229) L-glutamine import into cell(GO:1903803) |
| 0.3 |
2.3 |
GO:0014003 |
oligodendrocyte development(GO:0014003) |
| 0.3 |
3.0 |
GO:0000160 |
phosphorelay signal transduction system(GO:0000160) |
| 0.3 |
3.0 |
GO:0070172 |
positive regulation of tooth mineralization(GO:0070172) |
| 0.3 |
1.6 |
GO:0000720 |
pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
| 0.3 |
1.6 |
GO:0002865 |
negative regulation of acute inflammatory response to antigenic stimulus(GO:0002865) |
| 0.3 |
1.0 |
GO:1900126 |
negative regulation of hyaluronan biosynthetic process(GO:1900126) |
| 0.3 |
3.6 |
GO:0044821 |
meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
| 0.3 |
5.2 |
GO:0051599 |
response to hydrostatic pressure(GO:0051599) |
| 0.3 |
3.9 |
GO:0060689 |
cell differentiation involved in salivary gland development(GO:0060689) |
| 0.3 |
2.9 |
GO:0090037 |
positive regulation of protein kinase C signaling(GO:0090037) |
| 0.3 |
0.6 |
GO:0003215 |
cardiac right ventricle morphogenesis(GO:0003215) |
| 0.3 |
1.3 |
GO:0097278 |
complement-dependent cytotoxicity(GO:0097278) |
| 0.3 |
1.3 |
GO:1903715 |
regulation of aerobic respiration(GO:1903715) |
| 0.3 |
1.6 |
GO:0038169 |
somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
| 0.3 |
4.2 |
GO:1990440 |
positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
| 0.3 |
1.9 |
GO:0032060 |
bleb assembly(GO:0032060) |
| 0.3 |
1.3 |
GO:0016480 |
negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
| 0.3 |
0.3 |
GO:0030860 |
regulation of polarized epithelial cell differentiation(GO:0030860) |
| 0.3 |
2.6 |
GO:1902255 |
positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
| 0.3 |
1.0 |
GO:0007113 |
endomitotic cell cycle(GO:0007113) |
| 0.3 |
1.0 |
GO:0006620 |
posttranslational protein targeting to membrane(GO:0006620) |
| 0.3 |
1.0 |
GO:0035672 |
oligopeptide transmembrane transport(GO:0035672) |
| 0.3 |
1.0 |
GO:0006434 |
seryl-tRNA aminoacylation(GO:0006434) |
| 0.3 |
0.3 |
GO:2000410 |
regulation of thymocyte migration(GO:2000410) |
| 0.3 |
5.0 |
GO:2001028 |
positive regulation of endothelial cell chemotaxis(GO:2001028) |
| 0.3 |
1.6 |
GO:0007525 |
somatic muscle development(GO:0007525) |
| 0.3 |
1.3 |
GO:0021553 |
olfactory nerve development(GO:0021553) |
| 0.3 |
1.3 |
GO:0032494 |
response to peptidoglycan(GO:0032494) |
| 0.3 |
16.0 |
GO:0090662 |
ATP hydrolysis coupled transmembrane transport(GO:0090662) |
| 0.3 |
1.9 |
GO:0043248 |
proteasome assembly(GO:0043248) |
| 0.3 |
0.6 |
GO:0060214 |
endocardium formation(GO:0060214) |
| 0.3 |
0.3 |
GO:0035963 |
response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
| 0.3 |
1.6 |
GO:1904636 |
response to ionomycin(GO:1904636) cellular response to ionomycin(GO:1904637) |
| 0.3 |
1.6 |
GO:0060830 |
ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
| 0.3 |
2.5 |
GO:2001199 |
negative regulation of dendritic cell differentiation(GO:2001199) |
| 0.3 |
0.9 |
GO:0071418 |
cellular response to amine stimulus(GO:0071418) |
| 0.3 |
0.3 |
GO:0035802 |
adrenal cortex development(GO:0035801) adrenal cortex formation(GO:0035802) |
| 0.3 |
2.5 |
GO:0008228 |
opsonization(GO:0008228) |
| 0.3 |
0.3 |
GO:0014839 |
myoblast migration involved in skeletal muscle regeneration(GO:0014839) |
| 0.3 |
1.2 |
GO:0098968 |
neurotransmitter receptor transport postsynaptic membrane to endosome(GO:0098968) |
| 0.3 |
0.6 |
GO:0036506 |
maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
| 0.3 |
1.2 |
GO:0009298 |
GDP-mannose biosynthetic process(GO:0009298) |
| 0.3 |
0.9 |
GO:1903719 |
regulation of I-kappaB phosphorylation(GO:1903719) positive regulation of I-kappaB phosphorylation(GO:1903721) |
| 0.3 |
3.6 |
GO:0071028 |
nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
| 0.3 |
3.3 |
GO:1902455 |
negative regulation of stem cell population maintenance(GO:1902455) |
| 0.3 |
3.6 |
GO:0006689 |
ganglioside catabolic process(GO:0006689) |
| 0.3 |
2.4 |
GO:0060591 |
chondroblast differentiation(GO:0060591) |
| 0.3 |
1.8 |
GO:0052551 |
response to defense-related nitric oxide production by other organism involved in symbiotic interaction(GO:0052551) response to defense-related host nitric oxide production(GO:0052565) |
| 0.3 |
5.7 |
GO:0015886 |
heme transport(GO:0015886) |
| 0.3 |
0.3 |
GO:0021913 |
regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
| 0.3 |
0.3 |
GO:0003292 |
cardiac septum cell differentiation(GO:0003292) atrioventricular node cell differentiation(GO:0060922) atrioventricular node cell development(GO:0060928) |
| 0.3 |
0.9 |
GO:0035754 |
B cell chemotaxis(GO:0035754) |
| 0.3 |
6.5 |
GO:0006123 |
mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 0.3 |
4.1 |
GO:0032074 |
negative regulation of nuclease activity(GO:0032074) |
| 0.3 |
2.7 |
GO:0070236 |
negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 0.3 |
0.3 |
GO:1904322 |
response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
| 0.3 |
2.6 |
GO:0009111 |
vitamin catabolic process(GO:0009111) |
| 0.3 |
5.2 |
GO:0019532 |
oxalate transport(GO:0019532) |
| 0.3 |
7.0 |
GO:2000311 |
regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
| 0.3 |
0.3 |
GO:0006991 |
response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
| 0.3 |
0.6 |
GO:0051966 |
regulation of synaptic transmission, glutamatergic(GO:0051966) |
| 0.3 |
1.2 |
GO:0044691 |
tooth eruption(GO:0044691) |
| 0.3 |
1.4 |
GO:0014043 |
negative regulation of neuron maturation(GO:0014043) |
| 0.3 |
6.6 |
GO:0002076 |
osteoblast development(GO:0002076) |
| 0.3 |
2.9 |
GO:0035437 |
protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
| 0.3 |
1.1 |
GO:0006669 |
sphinganine-1-phosphate biosynthetic process(GO:0006669) |
| 0.3 |
1.4 |
GO:0090076 |
relaxation of skeletal muscle(GO:0090076) |
| 0.3 |
0.3 |
GO:0002589 |
negative regulation of antigen processing and presentation of peptide antigen(GO:0002584) regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) negative regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002590) |
| 0.3 |
2.8 |
GO:0045054 |
constitutive secretory pathway(GO:0045054) |
| 0.3 |
1.1 |
GO:0014054 |
positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
| 0.3 |
1.7 |
GO:0045591 |
positive regulation of regulatory T cell differentiation(GO:0045591) |
| 0.3 |
0.8 |
GO:2000588 |
positive regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000588) |
| 0.3 |
0.8 |
GO:0021979 |
hypothalamus cell differentiation(GO:0021979) |
| 0.3 |
3.4 |
GO:1902746 |
regulation of lens fiber cell differentiation(GO:1902746) |
| 0.3 |
2.0 |
GO:0032782 |
bile acid secretion(GO:0032782) |
| 0.3 |
5.5 |
GO:0006957 |
complement activation, alternative pathway(GO:0006957) |
| 0.3 |
0.6 |
GO:0021523 |
somatic motor neuron differentiation(GO:0021523) |
| 0.3 |
1.4 |
GO:1902268 |
negative regulation of polyamine transmembrane transport(GO:1902268) |
| 0.3 |
0.6 |
GO:1902958 |
detoxification of copper ion(GO:0010273) enzyme active site formation(GO:0018307) neuron death in response to hydrogen peroxide(GO:0036476) neuron intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:0036482) detoxification of mercury ion(GO:0050787) positive regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902958) regulation of hydrogen peroxide-induced neuron death(GO:1903207) negative regulation of hydrogen peroxide-induced neuron death(GO:1903208) regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway(GO:1903383) negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway(GO:1903384) stress response to copper ion(GO:1990169) regulation of cellular amino acid biosynthetic process(GO:2000282) |
| 0.3 |
1.1 |
GO:0044537 |
regulation of circulating fibrinogen levels(GO:0044537) |
| 0.3 |
0.6 |
GO:0021589 |
hindbrain structural organization(GO:0021577) cerebellum structural organization(GO:0021589) |
| 0.3 |
0.5 |
GO:1902065 |
response to L-glutamate(GO:1902065) |
| 0.3 |
0.5 |
GO:0006655 |
phosphatidylglycerol biosynthetic process(GO:0006655) |
| 0.3 |
3.8 |
GO:0030388 |
fructose 1,6-bisphosphate metabolic process(GO:0030388) |
| 0.3 |
0.3 |
GO:0045073 |
regulation of chemokine biosynthetic process(GO:0045073) |
| 0.3 |
2.4 |
GO:2001268 |
negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
| 0.3 |
1.9 |
GO:0071461 |
cellular response to redox state(GO:0071461) |
| 0.3 |
1.4 |
GO:0023035 |
CD40 signaling pathway(GO:0023035) |
| 0.3 |
1.1 |
GO:0007617 |
mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
| 0.3 |
0.3 |
GO:0016188 |
synaptic vesicle maturation(GO:0016188) |
| 0.3 |
1.6 |
GO:0046985 |
positive regulation of hemoglobin biosynthetic process(GO:0046985) |
| 0.3 |
0.5 |
GO:0021529 |
spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
| 0.3 |
0.8 |
GO:0070105 |
positive regulation of interleukin-6-mediated signaling pathway(GO:0070105) |
| 0.3 |
39.2 |
GO:0006614 |
SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
| 0.3 |
0.8 |
GO:0035349 |
coenzyme A transport(GO:0015880) coenzyme A transmembrane transport(GO:0035349) adenosine 3',5'-bisphosphate transmembrane transport(GO:0071106) AMP transport(GO:0080121) |
| 0.3 |
1.9 |
GO:0060356 |
leucine import(GO:0060356) |
| 0.3 |
0.5 |
GO:0001575 |
globoside metabolic process(GO:0001575) |
| 0.3 |
0.5 |
GO:1903976 |
negative regulation of glial cell migration(GO:1903976) |
| 0.3 |
1.3 |
GO:0060332 |
positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
| 0.3 |
3.2 |
GO:0006657 |
CDP-choline pathway(GO:0006657) |
| 0.3 |
0.5 |
GO:0060129 |
thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) |
| 0.3 |
4.0 |
GO:0035845 |
photoreceptor cell outer segment organization(GO:0035845) |
| 0.3 |
0.3 |
GO:2000790 |
regulation of mesenchymal cell proliferation involved in lung development(GO:2000790) negative regulation of mesenchymal cell proliferation involved in lung development(GO:2000791) |
| 0.3 |
8.2 |
GO:0008535 |
respiratory chain complex IV assembly(GO:0008535) |
| 0.3 |
1.6 |
GO:1902230 |
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
| 0.3 |
0.8 |
GO:0045212 |
negative regulation of synaptic transmission, cholinergic(GO:0032223) neurotransmitter receptor biosynthetic process(GO:0045212) |
| 0.3 |
5.2 |
GO:1990001 |
inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
| 0.3 |
0.5 |
GO:0046778 |
modification by virus of host mRNA processing(GO:0046778) |
| 0.3 |
1.6 |
GO:0010459 |
negative regulation of heart rate(GO:0010459) |
| 0.3 |
1.8 |
GO:1900194 |
negative regulation of oocyte maturation(GO:1900194) |
| 0.3 |
1.0 |
GO:1902990 |
mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
| 0.3 |
2.1 |
GO:0070315 |
G1 to G0 transition involved in cell differentiation(GO:0070315) |
| 0.3 |
0.8 |
GO:0030241 |
skeletal muscle myosin thick filament assembly(GO:0030241) |
| 0.3 |
1.8 |
GO:0019075 |
virus maturation(GO:0019075) |
| 0.3 |
1.8 |
GO:0032815 |
negative regulation of natural killer cell activation(GO:0032815) |
| 0.3 |
1.0 |
GO:0006287 |
base-excision repair, gap-filling(GO:0006287) |
| 0.3 |
2.5 |
GO:0002053 |
positive regulation of mesenchymal cell proliferation(GO:0002053) |
| 0.3 |
3.8 |
GO:0090385 |
phagosome-lysosome fusion(GO:0090385) |
| 0.3 |
4.8 |
GO:0030322 |
stabilization of membrane potential(GO:0030322) |
| 0.3 |
0.5 |
GO:1904861 |
postsynaptic density assembly(GO:0097107) gephyrin clustering involved in postsynaptic density assembly(GO:0097116) excitatory synapse assembly(GO:1904861) |
| 0.3 |
1.5 |
GO:2000676 |
positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
| 0.2 |
1.0 |
GO:1901165 |
positive regulation of trophoblast cell migration(GO:1901165) |
| 0.2 |
0.2 |
GO:2000977 |
regulation of forebrain neuron differentiation(GO:2000977) |
| 0.2 |
10.4 |
GO:1904659 |
hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
| 0.2 |
4.2 |
GO:1904152 |
regulation of retrograde protein transport, ER to cytosol(GO:1904152) |
| 0.2 |
1.7 |
GO:0032383 |
regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
| 0.2 |
1.2 |
GO:0010985 |
negative regulation of lipoprotein particle clearance(GO:0010985) negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
| 0.2 |
0.7 |
GO:0030070 |
insulin processing(GO:0030070) |
| 0.2 |
2.5 |
GO:0060770 |
negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
| 0.2 |
5.1 |
GO:0090023 |
positive regulation of neutrophil chemotaxis(GO:0090023) |
| 0.2 |
3.2 |
GO:0046322 |
negative regulation of fatty acid oxidation(GO:0046322) |
| 0.2 |
3.7 |
GO:0035414 |
negative regulation of catenin import into nucleus(GO:0035414) |
| 0.2 |
3.2 |
GO:0071550 |
death-inducing signaling complex assembly(GO:0071550) |
| 0.2 |
2.2 |
GO:0018916 |
nitrobenzene metabolic process(GO:0018916) |
| 0.2 |
0.5 |
GO:0002675 |
positive regulation of acute inflammatory response(GO:0002675) |
| 0.2 |
0.5 |
GO:1900166 |
glial cell-derived neurotrophic factor secretion(GO:0044467) regulation of glial cell-derived neurotrophic factor secretion(GO:1900166) positive regulation of glial cell-derived neurotrophic factor secretion(GO:1900168) |
| 0.2 |
0.2 |
GO:0071469 |
cellular response to alkaline pH(GO:0071469) |
| 0.2 |
3.1 |
GO:0007171 |
activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
| 0.2 |
5.7 |
GO:2000251 |
positive regulation of actin cytoskeleton reorganization(GO:2000251) |
| 0.2 |
0.5 |
GO:0046968 |
peptide antigen transport(GO:0046968) |
| 0.2 |
8.8 |
GO:0006735 |
NADH regeneration(GO:0006735) canonical glycolysis(GO:0061621) glucose catabolic process to pyruvate(GO:0061718) |
| 0.2 |
0.7 |
GO:0015881 |
creatine transport(GO:0015881) creatine transmembrane transport(GO:1902598) |
| 0.2 |
27.5 |
GO:0070125 |
mitochondrial translational elongation(GO:0070125) |
| 0.2 |
1.2 |
GO:0002690 |
positive regulation of leukocyte chemotaxis(GO:0002690) |
| 0.2 |
0.5 |
GO:0055099 |
response to high density lipoprotein particle(GO:0055099) |
| 0.2 |
1.9 |
GO:0045716 |
positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
| 0.2 |
0.5 |
GO:0070309 |
lens fiber cell morphogenesis(GO:0070309) |
| 0.2 |
0.7 |
GO:0031584 |
activation of phospholipase D activity(GO:0031584) |
| 0.2 |
17.1 |
GO:0006120 |
mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
| 0.2 |
4.9 |
GO:0006975 |
DNA damage induced protein phosphorylation(GO:0006975) |
| 0.2 |
2.6 |
GO:0036066 |
protein O-linked fucosylation(GO:0036066) |
| 0.2 |
0.2 |
GO:0030327 |
prenylated protein catabolic process(GO:0030327) |
| 0.2 |
0.2 |
GO:2000275 |
regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
| 0.2 |
0.9 |
GO:0046909 |
intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
| 0.2 |
0.2 |
GO:0002347 |
response to tumor cell(GO:0002347) |
| 0.2 |
3.0 |
GO:0048387 |
negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
| 0.2 |
1.4 |
GO:0039689 |
negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
| 0.2 |
3.5 |
GO:0035269 |
protein O-linked mannosylation(GO:0035269) |
| 0.2 |
2.1 |
GO:0021707 |
cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
| 0.2 |
0.5 |
GO:0060994 |
regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
| 0.2 |
4.1 |
GO:0045023 |
G0 to G1 transition(GO:0045023) |
| 0.2 |
2.0 |
GO:0046185 |
aldehyde catabolic process(GO:0046185) |
| 0.2 |
2.0 |
GO:0097091 |
synaptic vesicle clustering(GO:0097091) |
| 0.2 |
1.4 |
GO:0044650 |
adhesion of symbiont to host cell(GO:0044650) |
| 0.2 |
0.2 |
GO:2000118 |
regulation of sodium-dependent phosphate transport(GO:2000118) |
| 0.2 |
1.6 |
GO:0071440 |
regulation of histone H3-K14 acetylation(GO:0071440) positive regulation of histone H3-K14 acetylation(GO:0071442) |
| 0.2 |
0.7 |
GO:0061589 |
calcium activated phosphatidylserine scrambling(GO:0061589) |
| 0.2 |
0.5 |
GO:0070945 |
neutrophil mediated cytotoxicity(GO:0070942) neutrophil mediated killing of symbiont cell(GO:0070943) neutrophil mediated killing of bacterium(GO:0070944) neutrophil mediated killing of gram-negative bacterium(GO:0070945) |
| 0.2 |
0.2 |
GO:0097106 |
postsynaptic density organization(GO:0097106) |
| 0.2 |
1.1 |
GO:0042350 |
GDP-L-fucose biosynthetic process(GO:0042350) |
| 0.2 |
2.2 |
GO:0007144 |
female meiosis I(GO:0007144) |
| 0.2 |
0.7 |
GO:0009822 |
alkaloid catabolic process(GO:0009822) |
| 0.2 |
0.9 |
GO:0000379 |
tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 0.2 |
4.6 |
GO:0070208 |
protein heterotrimerization(GO:0070208) |
| 0.2 |
0.9 |
GO:1903026 |
negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
| 0.2 |
4.9 |
GO:0019372 |
lipoxygenase pathway(GO:0019372) |
| 0.2 |
4.0 |
GO:0048266 |
behavioral response to pain(GO:0048266) |
| 0.2 |
0.4 |
GO:0014707 |
branchiomeric skeletal muscle development(GO:0014707) |
| 0.2 |
0.4 |
GO:0002090 |
regulation of receptor internalization(GO:0002090) |
| 0.2 |
6.1 |
GO:0007625 |
grooming behavior(GO:0007625) |
| 0.2 |
12.9 |
GO:0000413 |
protein peptidyl-prolyl isomerization(GO:0000413) |
| 0.2 |
1.3 |
GO:0010968 |
regulation of microtubule nucleation(GO:0010968) |
| 0.2 |
1.7 |
GO:0051026 |
chiasma assembly(GO:0051026) |
| 0.2 |
0.7 |
GO:0007538 |
primary sex determination(GO:0007538) |
| 0.2 |
2.2 |
GO:2001166 |
regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
| 0.2 |
1.5 |
GO:0007256 |
activation of JNKK activity(GO:0007256) |
| 0.2 |
2.8 |
GO:0044062 |
regulation of excretion(GO:0044062) |
| 0.2 |
2.4 |
GO:0042711 |
maternal behavior(GO:0042711) parental behavior(GO:0060746) |
| 0.2 |
7.1 |
GO:0043030 |
regulation of macrophage activation(GO:0043030) |
| 0.2 |
0.2 |
GO:1901723 |
negative regulation of cell proliferation involved in kidney development(GO:1901723) |
| 0.2 |
0.4 |
GO:0045168 |
cell-cell signaling involved in cell fate commitment(GO:0045168) |
| 0.2 |
0.9 |
GO:0042670 |
retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
| 0.2 |
7.5 |
GO:0048025 |
negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
| 0.2 |
1.7 |
GO:0070164 |
negative regulation of adiponectin secretion(GO:0070164) |
| 0.2 |
6.2 |
GO:0007130 |
synaptonemal complex assembly(GO:0007130) |
| 0.2 |
1.1 |
GO:0070829 |
response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
| 0.2 |
0.4 |
GO:0010002 |
cardioblast differentiation(GO:0010002) |
| 0.2 |
2.3 |
GO:0061179 |
negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 0.2 |
1.5 |
GO:0048619 |
embryonic hindgut morphogenesis(GO:0048619) |
| 0.2 |
1.7 |
GO:0001774 |
microglial cell activation(GO:0001774) |
| 0.2 |
1.7 |
GO:0034134 |
toll-like receptor 2 signaling pathway(GO:0034134) |
| 0.2 |
0.8 |
GO:0019401 |
glycerol biosynthetic process(GO:0006114) alditol biosynthetic process(GO:0019401) |
| 0.2 |
0.2 |
GO:0002829 |
negative regulation of type 2 immune response(GO:0002829) |
| 0.2 |
0.6 |
GO:2000395 |
regulation of ubiquitin-dependent endocytosis(GO:2000395) positive regulation of ubiquitin-dependent endocytosis(GO:2000397) |
| 0.2 |
1.3 |
GO:0060536 |
cartilage morphogenesis(GO:0060536) |
| 0.2 |
0.6 |
GO:0034755 |
iron ion transmembrane transport(GO:0034755) |
| 0.2 |
2.3 |
GO:0090336 |
positive regulation of brown fat cell differentiation(GO:0090336) |
| 0.2 |
1.2 |
GO:0007354 |
zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
| 0.2 |
0.2 |
GO:0010701 |
positive regulation of norepinephrine secretion(GO:0010701) |
| 0.2 |
0.8 |
GO:0021940 |
positive regulation of cerebellar granule cell precursor proliferation(GO:0021940) |
| 0.2 |
0.2 |
GO:1903862 |
positive regulation of oxidative phosphorylation(GO:1903862) |
| 0.2 |
0.4 |
GO:1901857 |
positive regulation of cellular respiration(GO:1901857) |
| 0.2 |
0.8 |
GO:0050916 |
sensory perception of sweet taste(GO:0050916) |
| 0.2 |
0.2 |
GO:1903093 |
regulation of protein K48-linked deubiquitination(GO:1903093) negative regulation of protein K48-linked deubiquitination(GO:1903094) negative regulation of ubiquitin-specific protease activity(GO:2000157) |
| 0.2 |
3.9 |
GO:0010764 |
negative regulation of fibroblast migration(GO:0010764) |
| 0.2 |
1.2 |
GO:0071104 |
response to interleukin-9(GO:0071104) |
| 0.2 |
1.0 |
GO:2000671 |
regulation of motor neuron apoptotic process(GO:2000671) negative regulation of motor neuron apoptotic process(GO:2000672) |
| 0.2 |
1.2 |
GO:0032926 |
negative regulation of activin receptor signaling pathway(GO:0032926) |
| 0.2 |
1.4 |
GO:0097646 |
calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
| 0.2 |
2.6 |
GO:0035331 |
negative regulation of hippo signaling(GO:0035331) |
| 0.2 |
2.4 |
GO:0002924 |
negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
| 0.2 |
0.6 |
GO:1903056 |
regulation of melanosome organization(GO:1903056) |
| 0.2 |
0.6 |
GO:0006481 |
C-terminal protein methylation(GO:0006481) |
| 0.2 |
1.2 |
GO:0035799 |
ureter maturation(GO:0035799) |
| 0.2 |
0.8 |
GO:0048012 |
hepatocyte growth factor receptor signaling pathway(GO:0048012) |
| 0.2 |
0.6 |
GO:0034344 |
type III interferon production(GO:0034343) regulation of type III interferon production(GO:0034344) |
| 0.2 |
0.6 |
GO:0019348 |
dolichol metabolic process(GO:0019348) |
| 0.2 |
1.6 |
GO:0019262 |
N-acetylneuraminate catabolic process(GO:0019262) |
| 0.2 |
3.4 |
GO:0042832 |
defense response to protozoan(GO:0042832) |
| 0.2 |
0.8 |
GO:1903566 |
positive regulation of protein localization to cilium(GO:1903566) |
| 0.2 |
0.6 |
GO:2000909 |
regulation of cholesterol import(GO:0060620) regulation of sterol import(GO:2000909) |
| 0.2 |
0.6 |
GO:0070902 |
mitochondrial tRNA pseudouridine synthesis(GO:0070902) |
| 0.2 |
0.8 |
GO:0060040 |
retinal bipolar neuron differentiation(GO:0060040) |
| 0.2 |
2.5 |
GO:0051969 |
regulation of transmission of nerve impulse(GO:0051969) |
| 0.2 |
0.4 |
GO:0010936 |
negative regulation of macrophage cytokine production(GO:0010936) |
| 0.2 |
1.8 |
GO:0009227 |
nucleotide-sugar catabolic process(GO:0009227) |
| 0.2 |
5.3 |
GO:0000038 |
very long-chain fatty acid metabolic process(GO:0000038) |
| 0.2 |
4.3 |
GO:0042417 |
dopamine metabolic process(GO:0042417) |
| 0.2 |
3.7 |
GO:0032098 |
regulation of appetite(GO:0032098) |
| 0.2 |
1.2 |
GO:0070131 |
positive regulation of mitochondrial translation(GO:0070131) |
| 0.2 |
0.2 |
GO:0042092 |
type 2 immune response(GO:0042092) |
| 0.2 |
1.0 |
GO:1904252 |
negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
| 0.2 |
1.2 |
GO:2001151 |
regulation of renal water transport(GO:2001151) positive regulation of renal water transport(GO:2001153) |
| 0.2 |
1.3 |
GO:0015732 |
prostaglandin transport(GO:0015732) |
| 0.2 |
0.8 |
GO:0097021 |
lymphocyte migration into lymphoid organs(GO:0097021) |
| 0.2 |
2.7 |
GO:2000766 |
negative regulation of cytoplasmic translation(GO:2000766) |
| 0.2 |
0.2 |
GO:0090086 |
negative regulation of protein deubiquitination(GO:0090086) |
| 0.2 |
5.1 |
GO:0007220 |
Notch receptor processing(GO:0007220) |
| 0.2 |
1.3 |
GO:0051697 |
protein delipidation(GO:0051697) |
| 0.2 |
3.8 |
GO:0034380 |
high-density lipoprotein particle assembly(GO:0034380) |
| 0.2 |
1.5 |
GO:0060219 |
camera-type eye photoreceptor cell differentiation(GO:0060219) |
| 0.2 |
4.3 |
GO:0043011 |
myeloid dendritic cell differentiation(GO:0043011) |
| 0.2 |
1.3 |
GO:0060672 |
epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 0.2 |
0.9 |
GO:0046855 |
phosphorylated carbohydrate dephosphorylation(GO:0046838) inositol phosphate dephosphorylation(GO:0046855) |
| 0.2 |
0.6 |
GO:0071139 |
resolution of recombination intermediates(GO:0071139) resolution of mitotic recombination intermediates(GO:0071140) |
| 0.2 |
0.7 |
GO:0098582 |
innate vocalization behavior(GO:0098582) |
| 0.2 |
1.3 |
GO:0048745 |
smooth muscle tissue development(GO:0048745) |
| 0.2 |
1.8 |
GO:0006931 |
substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 0.2 |
1.3 |
GO:0016139 |
glycoside catabolic process(GO:0016139) |
| 0.2 |
2.4 |
GO:0014722 |
regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
| 0.2 |
4.3 |
GO:1901663 |
ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
| 0.2 |
0.2 |
GO:0002074 |
extraocular skeletal muscle development(GO:0002074) |
| 0.2 |
0.4 |
GO:0071316 |
cellular response to nicotine(GO:0071316) |
| 0.2 |
0.9 |
GO:0061086 |
negative regulation of histone H3-K27 methylation(GO:0061086) |
| 0.2 |
2.5 |
GO:0071415 |
cellular response to purine-containing compound(GO:0071415) |
| 0.2 |
2.0 |
GO:0021860 |
pyramidal neuron development(GO:0021860) |
| 0.2 |
0.2 |
GO:0045763 |
negative regulation of cellular amino acid metabolic process(GO:0045763) |
| 0.2 |
0.5 |
GO:0075071 |
autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
| 0.2 |
0.5 |
GO:2000820 |
negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000820) |
| 0.2 |
1.4 |
GO:0030050 |
vesicle transport along actin filament(GO:0030050) |
| 0.2 |
0.5 |
GO:0070901 |
mitochondrial tRNA methylation(GO:0070901) |
| 0.2 |
0.9 |
GO:0060716 |
labyrinthine layer blood vessel development(GO:0060716) |
| 0.2 |
0.9 |
GO:0035726 |
common myeloid progenitor cell proliferation(GO:0035726) |
| 0.2 |
4.6 |
GO:0070886 |
positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
| 0.2 |
0.2 |
GO:0010692 |
regulation of alkaline phosphatase activity(GO:0010692) |
| 0.2 |
1.2 |
GO:0046604 |
positive regulation of mitotic centrosome separation(GO:0046604) |
| 0.2 |
0.3 |
GO:0042494 |
detection of bacterial lipoprotein(GO:0042494) |
| 0.2 |
0.3 |
GO:1903430 |
negative regulation of cell maturation(GO:1903430) |
| 0.2 |
1.6 |
GO:1903361 |
protein localization to basolateral plasma membrane(GO:1903361) |
| 0.2 |
0.3 |
GO:0045348 |
positive regulation of MHC class II biosynthetic process(GO:0045348) |
| 0.2 |
0.7 |
GO:0010831 |
positive regulation of myotube differentiation(GO:0010831) |
| 0.2 |
1.4 |
GO:0044211 |
CTP salvage(GO:0044211) |
| 0.2 |
5.5 |
GO:0001580 |
detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
| 0.2 |
2.6 |
GO:0033689 |
negative regulation of osteoblast proliferation(GO:0033689) |
| 0.2 |
1.0 |
GO:0051715 |
cytolysis in other organism(GO:0051715) |
| 0.2 |
0.2 |
GO:1902617 |
response to fluoride(GO:1902617) |
| 0.2 |
2.6 |
GO:0097369 |
sodium ion import(GO:0097369) |
| 0.2 |
0.3 |
GO:2000744 |
anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
| 0.2 |
0.5 |
GO:0046271 |
phenylpropanoid catabolic process(GO:0046271) |
| 0.2 |
1.0 |
GO:0050957 |
equilibrioception(GO:0050957) |
| 0.2 |
1.0 |
GO:0043950 |
positive regulation of cAMP-mediated signaling(GO:0043950) |
| 0.2 |
2.5 |
GO:0098828 |
positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
| 0.2 |
0.3 |
GO:0060272 |
embryonic skeletal joint morphogenesis(GO:0060272) |
| 0.2 |
0.7 |
GO:0019373 |
epoxygenase P450 pathway(GO:0019373) |
| 0.2 |
0.7 |
GO:0015785 |
UDP-galactose transport(GO:0015785) UDP-galactose transmembrane transport(GO:0072334) |
| 0.2 |
0.7 |
GO:0061760 |
antifungal innate immune response(GO:0061760) |
| 0.2 |
0.3 |
GO:0042335 |
cuticle development(GO:0042335) |
| 0.2 |
2.3 |
GO:0050713 |
negative regulation of interleukin-1 beta secretion(GO:0050713) |
| 0.2 |
1.3 |
GO:0031119 |
tRNA pseudouridine synthesis(GO:0031119) |
| 0.2 |
1.1 |
GO:0038003 |
opioid receptor signaling pathway(GO:0038003) |
| 0.2 |
0.8 |
GO:2000313 |
fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
| 0.2 |
1.1 |
GO:0006572 |
tyrosine catabolic process(GO:0006572) |
| 0.2 |
0.7 |
GO:0019369 |
arachidonic acid metabolic process(GO:0019369) |
| 0.2 |
1.0 |
GO:0042756 |
drinking behavior(GO:0042756) |
| 0.2 |
1.0 |
GO:0007168 |
receptor guanylyl cyclase signaling pathway(GO:0007168) |
| 0.2 |
1.1 |
GO:0048663 |
neuron fate commitment(GO:0048663) |
| 0.2 |
1.8 |
GO:0000389 |
mRNA 3'-splice site recognition(GO:0000389) |
| 0.2 |
0.8 |
GO:0098532 |
histone H3-K27 trimethylation(GO:0098532) |
| 0.2 |
1.1 |
GO:0030579 |
ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
| 0.2 |
1.1 |
GO:0016199 |
axon midline choice point recognition(GO:0016199) |
| 0.2 |
0.2 |
GO:1990009 |
retinal cell apoptotic process(GO:1990009) |
| 0.2 |
1.9 |
GO:0044550 |
melanin metabolic process(GO:0006582) melanin biosynthetic process(GO:0042438) secondary metabolite biosynthetic process(GO:0044550) |
| 0.2 |
0.6 |
GO:0019626 |
short-chain fatty acid catabolic process(GO:0019626) |
| 0.2 |
0.6 |
GO:0014047 |
glutamate secretion(GO:0014047) |
| 0.2 |
0.3 |
GO:2000253 |
positive regulation of feeding behavior(GO:2000253) |
| 0.2 |
2.1 |
GO:0070884 |
regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
| 0.2 |
0.6 |
GO:0045075 |
interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
| 0.2 |
0.6 |
GO:0048205 |
COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
| 0.2 |
5.0 |
GO:0019228 |
neuronal action potential(GO:0019228) |
| 0.2 |
1.9 |
GO:0060180 |
female mating behavior(GO:0060180) |
| 0.2 |
0.2 |
GO:2000851 |
positive regulation of cortisol secretion(GO:0051464) positive regulation of glucocorticoid secretion(GO:2000851) |
| 0.2 |
3.3 |
GO:0019835 |
cytolysis(GO:0019835) |
| 0.2 |
0.6 |
GO:1902766 |
skeletal muscle satellite cell migration(GO:1902766) |
| 0.2 |
1.4 |
GO:0006122 |
mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
| 0.2 |
0.3 |
GO:0002669 |
positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
| 0.2 |
0.5 |
GO:0035526 |
retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.2 |
0.5 |
GO:0018012 |
N-terminal peptidyl-alanine methylation(GO:0018011) N-terminal peptidyl-alanine trimethylation(GO:0018012) N-terminal peptidyl-glycine methylation(GO:0018013) N-terminal peptidyl-proline dimethylation(GO:0018016) peptidyl-alanine modification(GO:0018194) N-terminal peptidyl-proline methylation(GO:0035568) N-terminal peptidyl-serine methylation(GO:0035570) N-terminal peptidyl-serine dimethylation(GO:0035572) N-terminal peptidyl-serine trimethylation(GO:0035573) |
| 0.2 |
2.6 |
GO:0002523 |
leukocyte migration involved in inflammatory response(GO:0002523) |
| 0.2 |
1.6 |
GO:0043985 |
histone H4-R3 methylation(GO:0043985) |
| 0.2 |
1.2 |
GO:0051725 |
protein de-ADP-ribosylation(GO:0051725) |
| 0.2 |
0.5 |
GO:0060829 |
regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060827) negative regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060829) |
| 0.2 |
1.2 |
GO:0019236 |
response to pheromone(GO:0019236) |
| 0.2 |
0.9 |
GO:0021527 |
spinal cord association neuron differentiation(GO:0021527) |
| 0.2 |
2.3 |
GO:0006388 |
tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
| 0.2 |
1.2 |
GO:0006659 |
phosphatidylserine biosynthetic process(GO:0006659) |
| 0.2 |
1.1 |
GO:0042989 |
sequestering of actin monomers(GO:0042989) |
| 0.2 |
0.5 |
GO:0006598 |
polyamine catabolic process(GO:0006598) |
| 0.2 |
3.2 |
GO:0031163 |
iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 0.2 |
1.5 |
GO:0098734 |
macromolecule depalmitoylation(GO:0098734) |
| 0.2 |
0.9 |
GO:0009146 |
purine nucleoside triphosphate catabolic process(GO:0009146) |
| 0.1 |
1.6 |
GO:0015747 |
urate transport(GO:0015747) |
| 0.1 |
2.2 |
GO:0006527 |
arginine catabolic process(GO:0006527) |
| 0.1 |
0.4 |
GO:0071529 |
cementum mineralization(GO:0071529) |
| 0.1 |
0.9 |
GO:0001867 |
complement activation, lectin pathway(GO:0001867) |
| 0.1 |
0.6 |
GO:0045586 |
regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
| 0.1 |
0.3 |
GO:0035356 |
cellular triglyceride homeostasis(GO:0035356) |
| 0.1 |
1.9 |
GO:0015889 |
cobalamin transport(GO:0015889) |
| 0.1 |
0.4 |
GO:0006742 |
NADP catabolic process(GO:0006742) pyridine nucleotide catabolic process(GO:0019364) |
| 0.1 |
0.4 |
GO:0002426 |
immunoglobulin production in mucosal tissue(GO:0002426) |
| 0.1 |
1.3 |
GO:0046500 |
S-adenosylmethionine metabolic process(GO:0046500) |
| 0.1 |
0.4 |
GO:0046015 |
regulation of transcription by glucose(GO:0046015) |
| 0.1 |
0.6 |
GO:0048073 |
regulation of eye pigmentation(GO:0048073) |
| 0.1 |
1.0 |
GO:0098912 |
membrane depolarization during AV node cell action potential(GO:0086045) membrane depolarization during atrial cardiac muscle cell action potential(GO:0098912) |
| 0.1 |
3.5 |
GO:0060334 |
regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
| 0.1 |
0.7 |
GO:0071498 |
cellular response to fluid shear stress(GO:0071498) |
| 0.1 |
1.2 |
GO:0045837 |
negative regulation of membrane potential(GO:0045837) |
| 0.1 |
0.6 |
GO:0033625 |
positive regulation of integrin activation(GO:0033625) |
| 0.1 |
1.3 |
GO:0006782 |
protoporphyrinogen IX biosynthetic process(GO:0006782) |
| 0.1 |
0.6 |
GO:0042796 |
snRNA transcription from RNA polymerase III promoter(GO:0042796) |
| 0.1 |
0.9 |
GO:0071169 |
establishment of protein localization to chromatin(GO:0071169) |
| 0.1 |
3.3 |
GO:0030970 |
retrograde protein transport, ER to cytosol(GO:0030970) |
| 0.1 |
0.1 |
GO:0061101 |
neuroendocrine cell differentiation(GO:0061101) |
| 0.1 |
8.0 |
GO:0050650 |
chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
| 0.1 |
0.7 |
GO:0006489 |
dolichyl diphosphate biosynthetic process(GO:0006489) dolichyl diphosphate metabolic process(GO:0046465) |
| 0.1 |
0.7 |
GO:0032957 |
inositol trisphosphate metabolic process(GO:0032957) |
| 0.1 |
0.6 |
GO:0030573 |
bile acid catabolic process(GO:0030573) |
| 0.1 |
0.6 |
GO:0009236 |
cobalamin biosynthetic process(GO:0009236) |
| 0.1 |
1.7 |
GO:0035721 |
intraciliary retrograde transport(GO:0035721) |
| 0.1 |
0.8 |
GO:0021978 |
telencephalon regionalization(GO:0021978) |
| 0.1 |
2.8 |
GO:0006068 |
ethanol catabolic process(GO:0006068) |
| 0.1 |
2.7 |
GO:0019371 |
cyclooxygenase pathway(GO:0019371) |
| 0.1 |
0.4 |
GO:0007185 |
transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
| 0.1 |
0.1 |
GO:0060179 |
male mating behavior(GO:0060179) |
| 0.1 |
0.6 |
GO:1904715 |
negative regulation of chaperone-mediated autophagy(GO:1904715) |
| 0.1 |
1.8 |
GO:0070734 |
histone H3-K27 methylation(GO:0070734) |
| 0.1 |
1.8 |
GO:1901970 |
positive regulation of mitotic metaphase/anaphase transition(GO:0045842) positive regulation of mitotic sister chromatid separation(GO:1901970) positive regulation of metaphase/anaphase transition of cell cycle(GO:1902101) |
| 0.1 |
1.0 |
GO:1904381 |
Golgi apparatus mannose trimming(GO:1904381) |
| 0.1 |
2.1 |
GO:2000651 |
positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
| 0.1 |
1.0 |
GO:0002315 |
marginal zone B cell differentiation(GO:0002315) |
| 0.1 |
0.5 |
GO:0015742 |
alpha-ketoglutarate transport(GO:0015742) |
| 0.1 |
1.8 |
GO:0032793 |
positive regulation of CREB transcription factor activity(GO:0032793) |
| 0.1 |
0.4 |
GO:0038145 |
macrophage colony-stimulating factor signaling pathway(GO:0038145) |
| 0.1 |
1.6 |
GO:1904714 |
regulation of chaperone-mediated autophagy(GO:1904714) |
| 0.1 |
0.4 |
GO:0007217 |
tachykinin receptor signaling pathway(GO:0007217) |
| 0.1 |
4.6 |
GO:0016339 |
calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
| 0.1 |
0.3 |
GO:0050912 |
detection of chemical stimulus involved in sensory perception of taste(GO:0050912) |
| 0.1 |
0.7 |
GO:0061051 |
positive regulation of cell growth involved in cardiac muscle cell development(GO:0061051) |
| 0.1 |
0.4 |
GO:0030186 |
melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
| 0.1 |
1.8 |
GO:1900449 |
regulation of glutamate receptor signaling pathway(GO:1900449) |
| 0.1 |
0.3 |
GO:0060174 |
limb bud formation(GO:0060174) |
| 0.1 |
0.4 |
GO:0060381 |
regulation of single-stranded telomeric DNA binding(GO:0060380) positive regulation of single-stranded telomeric DNA binding(GO:0060381) |
| 0.1 |
0.4 |
GO:0006667 |
sphinganine metabolic process(GO:0006667) |
| 0.1 |
0.5 |
GO:0071371 |
cellular response to gonadotropin stimulus(GO:0071371) |
| 0.1 |
0.7 |
GO:0090156 |
cellular sphingolipid homeostasis(GO:0090156) |
| 0.1 |
2.7 |
GO:0035988 |
chondrocyte proliferation(GO:0035988) |
| 0.1 |
0.3 |
GO:0030259 |
lipid glycosylation(GO:0030259) |
| 0.1 |
0.4 |
GO:0051967 |
negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
| 0.1 |
1.3 |
GO:0048265 |
response to pain(GO:0048265) |
| 0.1 |
0.5 |
GO:0033173 |
calcineurin-NFAT signaling cascade(GO:0033173) |
| 0.1 |
0.4 |
GO:1903461 |
Okazaki fragment processing involved in mitotic DNA replication(GO:1903461) |
| 0.1 |
2.4 |
GO:0042340 |
keratan sulfate catabolic process(GO:0042340) |
| 0.1 |
1.8 |
GO:0048557 |
embryonic digestive tract morphogenesis(GO:0048557) |
| 0.1 |
0.4 |
GO:0006427 |
histidyl-tRNA aminoacylation(GO:0006427) |
| 0.1 |
0.3 |
GO:0048672 |
positive regulation of collateral sprouting(GO:0048672) |
| 0.1 |
0.4 |
GO:1904616 |
regulation of actin filament binding(GO:1904529) negative regulation of actin filament binding(GO:1904530) regulation of actin binding(GO:1904616) negative regulation of actin binding(GO:1904617) |
| 0.1 |
0.5 |
GO:0021797 |
forebrain anterior/posterior pattern specification(GO:0021797) |
| 0.1 |
0.9 |
GO:2000124 |
regulation of endocannabinoid signaling pathway(GO:2000124) |
| 0.1 |
0.5 |
GO:1904806 |
regulation of protein oxidation(GO:1904806) positive regulation of protein oxidation(GO:1904808) |
| 0.1 |
2.1 |
GO:0043562 |
cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.1 |
0.5 |
GO:0032474 |
otolith morphogenesis(GO:0032474) otolith development(GO:0048840) |
| 0.1 |
0.2 |
GO:0070091 |
glucagon secretion(GO:0070091) regulation of glucagon secretion(GO:0070092) |
| 0.1 |
0.4 |
GO:0006987 |
activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
| 0.1 |
1.7 |
GO:0044130 |
negative regulation of growth of symbiont in host(GO:0044130) |
| 0.1 |
0.4 |
GO:0060431 |
primary lung bud formation(GO:0060431) |
| 0.1 |
1.4 |
GO:0017183 |
peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
| 0.1 |
0.2 |
GO:0043615 |
astrocyte cell migration(GO:0043615) |
| 0.1 |
0.4 |
GO:0046521 |
sphingoid catabolic process(GO:0046521) |
| 0.1 |
3.3 |
GO:0097502 |
mannosylation(GO:0097502) |
| 0.1 |
1.6 |
GO:0018230 |
peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 0.1 |
0.7 |
GO:0070940 |
dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.1 |
1.8 |
GO:0006012 |
galactose metabolic process(GO:0006012) |
| 0.1 |
0.1 |
GO:2000196 |
positive regulation of female gonad development(GO:2000196) |
| 0.1 |
1.8 |
GO:0006554 |
lysine catabolic process(GO:0006554) |
| 0.1 |
11.8 |
GO:0006635 |
fatty acid beta-oxidation(GO:0006635) |
| 0.1 |
0.5 |
GO:0043129 |
surfactant homeostasis(GO:0043129) |
| 0.1 |
0.1 |
GO:0052047 |
interaction with other organism via secreted substance involved in symbiotic interaction(GO:0052047) |
| 0.1 |
0.2 |
GO:0045617 |
negative regulation of keratinocyte differentiation(GO:0045617) |
| 0.1 |
7.4 |
GO:0007218 |
neuropeptide signaling pathway(GO:0007218) |
| 0.1 |
0.5 |
GO:0035377 |
transepithelial water transport(GO:0035377) |
| 0.1 |
7.7 |
GO:0002279 |
mast cell activation involved in immune response(GO:0002279) mast cell degranulation(GO:0043303) |
| 0.1 |
1.2 |
GO:0002943 |
tRNA dihydrouridine synthesis(GO:0002943) |
| 0.1 |
0.9 |
GO:0035641 |
locomotory exploration behavior(GO:0035641) |
| 0.1 |
0.8 |
GO:0070370 |
heat acclimation(GO:0010286) cellular heat acclimation(GO:0070370) |
| 0.1 |
1.5 |
GO:0009235 |
cobalamin metabolic process(GO:0009235) |
| 0.1 |
0.6 |
GO:0043932 |
ossification involved in bone remodeling(GO:0043932) |
| 0.1 |
1.0 |
GO:0001973 |
adenosine receptor signaling pathway(GO:0001973) |
| 0.1 |
0.3 |
GO:0071963 |
establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
| 0.1 |
1.6 |
GO:0036149 |
phosphatidylinositol acyl-chain remodeling(GO:0036149) |
| 0.1 |
0.7 |
GO:1990834 |
response to odorant(GO:1990834) |
| 0.1 |
0.5 |
GO:0015766 |
disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 0.1 |
0.3 |
GO:0060988 |
lipid tube assembly(GO:0060988) |
| 0.1 |
0.5 |
GO:0033085 |
negative regulation of T cell differentiation in thymus(GO:0033085) negative regulation of thymocyte aggregation(GO:2000399) |
| 0.1 |
0.2 |
GO:0042348 |
regulation of NF-kappaB import into nucleus(GO:0042345) NF-kappaB import into nucleus(GO:0042348) |
| 0.1 |
0.9 |
GO:2000188 |
regulation of cholesterol homeostasis(GO:2000188) |
| 0.1 |
0.3 |
GO:0016198 |
axon choice point recognition(GO:0016198) |
| 0.1 |
0.8 |
GO:0002175 |
protein localization to paranode region of axon(GO:0002175) |
| 0.1 |
1.1 |
GO:0086024 |
adrenergic receptor signaling pathway involved in positive regulation of heart rate(GO:0086024) |
| 0.1 |
0.7 |
GO:0099538 |
synaptic signaling via neuropeptide(GO:0099538) trans-synaptic signaling by neuropeptide(GO:0099540) trans-synaptic signaling by neuropeptide, modulating synaptic transmission(GO:0099551) |
| 0.1 |
0.7 |
GO:0090241 |
negative regulation of histone H4 acetylation(GO:0090241) |
| 0.1 |
0.1 |
GO:1990086 |
lens fiber cell apoptotic process(GO:1990086) |
| 0.1 |
0.4 |
GO:1903859 |
regulation of dendrite extension(GO:1903859) |
| 0.1 |
9.8 |
GO:0006521 |
regulation of cellular amino acid metabolic process(GO:0006521) |
| 0.1 |
3.7 |
GO:0051350 |
negative regulation of lyase activity(GO:0051350) |
| 0.1 |
1.0 |
GO:0017196 |
N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 0.1 |
1.5 |
GO:0090315 |
negative regulation of protein targeting to membrane(GO:0090315) |
| 0.1 |
0.7 |
GO:0006119 |
oxidative phosphorylation(GO:0006119) |
| 0.1 |
1.2 |
GO:0016560 |
protein import into peroxisome matrix, docking(GO:0016560) |
| 0.1 |
1.4 |
GO:1901741 |
positive regulation of myoblast fusion(GO:1901741) |
| 0.1 |
1.5 |
GO:0000733 |
DNA strand renaturation(GO:0000733) |
| 0.1 |
0.6 |
GO:0051593 |
response to folic acid(GO:0051593) |
| 0.1 |
0.5 |
GO:2000483 |
negative regulation of interleukin-8 secretion(GO:2000483) |
| 0.1 |
0.6 |
GO:1901387 |
positive regulation of voltage-gated calcium channel activity(GO:1901387) |
| 0.1 |
0.1 |
GO:0010845 |
positive regulation of reciprocal meiotic recombination(GO:0010845) |
| 0.1 |
0.4 |
GO:0010523 |
negative regulation of calcium ion transport into cytosol(GO:0010523) |
| 0.1 |
4.1 |
GO:0032570 |
response to progesterone(GO:0032570) |
| 0.1 |
0.2 |
GO:0043376 |
regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
| 0.1 |
0.6 |
GO:0009247 |
glycolipid biosynthetic process(GO:0009247) |
| 0.1 |
1.3 |
GO:0042940 |
D-amino acid transport(GO:0042940) |
| 0.1 |
1.1 |
GO:0042074 |
cell migration involved in gastrulation(GO:0042074) |
| 0.1 |
1.7 |
GO:0036150 |
phosphatidylserine acyl-chain remodeling(GO:0036150) |
| 0.1 |
2.2 |
GO:0036158 |
outer dynein arm assembly(GO:0036158) |
| 0.1 |
0.5 |
GO:2000312 |
regulation of kainate selective glutamate receptor activity(GO:2000312) |
| 0.1 |
1.5 |
GO:0071688 |
striated muscle myosin thick filament assembly(GO:0071688) |
| 0.1 |
1.9 |
GO:0019511 |
peptidyl-proline hydroxylation(GO:0019511) |
| 0.1 |
0.2 |
GO:0002903 |
negative regulation of B cell apoptotic process(GO:0002903) |
| 0.1 |
0.2 |
GO:0009786 |
regulation of asymmetric cell division(GO:0009786) |
| 0.1 |
0.5 |
GO:0006001 |
fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) |
| 0.1 |
0.5 |
GO:0045065 |
cytotoxic T cell differentiation(GO:0045065) |
| 0.1 |
0.5 |
GO:0048749 |
compound eye development(GO:0048749) |
| 0.1 |
0.2 |
GO:0060539 |
diaphragm development(GO:0060539) |
| 0.1 |
0.5 |
GO:0071350 |
interleukin-15-mediated signaling pathway(GO:0035723) cellular response to interleukin-15(GO:0071350) |
| 0.1 |
1.4 |
GO:0045956 |
positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
| 0.1 |
0.4 |
GO:0035609 |
C-terminal protein deglutamylation(GO:0035609) |
| 0.1 |
0.5 |
GO:0045869 |
negative regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045869) |
| 0.1 |
0.2 |
GO:0061055 |
myotome development(GO:0061055) |
| 0.1 |
2.2 |
GO:0001574 |
ganglioside biosynthetic process(GO:0001574) |
| 0.1 |
0.3 |
GO:0001777 |
T cell homeostatic proliferation(GO:0001777) |
| 0.1 |
1.0 |
GO:0036342 |
post-anal tail morphogenesis(GO:0036342) |
| 0.1 |
0.5 |
GO:0006837 |
serotonin transport(GO:0006837) serotonin uptake(GO:0051610) |
| 0.1 |
1.2 |
GO:0019934 |
cGMP-mediated signaling(GO:0019934) |
| 0.1 |
0.4 |
GO:0090362 |
positive regulation of platelet-derived growth factor production(GO:0090362) |
| 0.1 |
0.2 |
GO:0016999 |
antibiotic metabolic process(GO:0016999) |
| 0.1 |
0.2 |
GO:0002625 |
regulation of T cell antigen processing and presentation(GO:0002625) |
| 0.1 |
0.2 |
GO:0036324 |
vascular endothelial growth factor receptor-2 signaling pathway(GO:0036324) |
| 0.1 |
0.4 |
GO:0033605 |
positive regulation of catecholamine secretion(GO:0033605) |
| 0.1 |
0.7 |
GO:0039692 |
single stranded viral RNA replication via double stranded DNA intermediate(GO:0039692) |
| 0.1 |
0.7 |
GO:0048169 |
regulation of long-term neuronal synaptic plasticity(GO:0048169) |
| 0.1 |
0.8 |
GO:0015860 |
purine nucleoside transmembrane transport(GO:0015860) |
| 0.1 |
0.5 |
GO:1900193 |
regulation of oocyte maturation(GO:1900193) |
| 0.1 |
1.0 |
GO:0030502 |
negative regulation of bone mineralization(GO:0030502) |
| 0.1 |
0.1 |
GO:0071042 |
nuclear polyadenylation-dependent mRNA catabolic process(GO:0071042) polyadenylation-dependent mRNA catabolic process(GO:0071047) |
| 0.1 |
2.5 |
GO:0008033 |
tRNA processing(GO:0008033) |
| 0.1 |
1.5 |
GO:0070286 |
axonemal dynein complex assembly(GO:0070286) |
| 0.1 |
0.2 |
GO:0003289 |
atrial septum primum morphogenesis(GO:0003289) |
| 0.1 |
0.7 |
GO:0010944 |
negative regulation of transcription by competitive promoter binding(GO:0010944) |
| 0.1 |
1.4 |
GO:0042167 |
porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
| 0.1 |
0.1 |
GO:1901374 |
acetylcholine transport(GO:0015870) acetate ester transport(GO:1901374) |
| 0.1 |
0.2 |
GO:0034227 |
tRNA thio-modification(GO:0034227) |
| 0.1 |
0.7 |
GO:0001964 |
startle response(GO:0001964) |
| 0.1 |
1.6 |
GO:0007263 |
nitric oxide mediated signal transduction(GO:0007263) |
| 0.1 |
1.2 |
GO:1902259 |
regulation of delayed rectifier potassium channel activity(GO:1902259) |
| 0.1 |
0.1 |
GO:0060029 |
convergent extension involved in organogenesis(GO:0060029) |
| 0.1 |
0.3 |
GO:0045074 |
interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
| 0.1 |
0.3 |
GO:0061056 |
sclerotome development(GO:0061056) |
| 0.1 |
0.4 |
GO:0010756 |
positive regulation of plasminogen activation(GO:0010756) |
| 0.1 |
1.0 |
GO:0015760 |
hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.1 |
2.1 |
GO:0006703 |
estrogen biosynthetic process(GO:0006703) |
| 0.1 |
0.7 |
GO:0001561 |
fatty acid alpha-oxidation(GO:0001561) |
| 0.1 |
0.3 |
GO:0033319 |
UDP-D-xylose metabolic process(GO:0033319) UDP-D-xylose biosynthetic process(GO:0033320) |
| 0.1 |
0.8 |
GO:0007213 |
G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
| 0.1 |
3.4 |
GO:0097503 |
sialylation(GO:0097503) |
| 0.1 |
0.6 |
GO:0016998 |
cell wall macromolecule catabolic process(GO:0016998) |
| 0.1 |
0.3 |
GO:0051195 |
negative regulation of glycolytic process(GO:0045820) negative regulation of cofactor metabolic process(GO:0051195) negative regulation of coenzyme metabolic process(GO:0051198) |
| 0.1 |
6.2 |
GO:0051965 |
positive regulation of synapse assembly(GO:0051965) |
| 0.1 |
5.8 |
GO:0006414 |
translational elongation(GO:0006414) |
| 0.1 |
0.2 |
GO:0099640 |
axo-dendritic protein transport(GO:0099640) |
| 0.1 |
0.4 |
GO:0055069 |
zinc ion homeostasis(GO:0055069) |
| 0.1 |
0.4 |
GO:0046541 |
saliva secretion(GO:0046541) |
| 0.1 |
1.1 |
GO:0014870 |
response to muscle inactivity(GO:0014870) |
| 0.1 |
0.5 |
GO:0046874 |
quinolinate metabolic process(GO:0046874) |
| 0.1 |
1.6 |
GO:0007597 |
blood coagulation, intrinsic pathway(GO:0007597) |
| 0.1 |
2.9 |
GO:0035235 |
ionotropic glutamate receptor signaling pathway(GO:0035235) |
| 0.1 |
0.2 |
GO:1901383 |
negative regulation of chorionic trophoblast cell proliferation(GO:1901383) |
| 0.1 |
0.8 |
GO:0090500 |
endocardial cushion to mesenchymal transition(GO:0090500) |
| 0.1 |
0.8 |
GO:0048240 |
sperm capacitation(GO:0048240) |
| 0.1 |
0.5 |
GO:0031914 |
negative regulation of synaptic plasticity(GO:0031914) |
| 0.1 |
0.9 |
GO:0006584 |
catecholamine metabolic process(GO:0006584) catechol-containing compound metabolic process(GO:0009712) |
| 0.1 |
0.7 |
GO:0014067 |
negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
| 0.1 |
0.2 |
GO:0038163 |
thrombopoietin-mediated signaling pathway(GO:0038163) |
| 0.1 |
0.3 |
GO:0014883 |
transition between fast and slow fiber(GO:0014883) |
| 0.1 |
1.5 |
GO:0006517 |
protein deglycosylation(GO:0006517) |
| 0.1 |
1.2 |
GO:0043653 |
mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
| 0.1 |
0.6 |
GO:1903575 |
cornified envelope assembly(GO:1903575) |
| 0.1 |
2.2 |
GO:0046339 |
diacylglycerol metabolic process(GO:0046339) |
| 0.1 |
0.1 |
GO:0098735 |
positive regulation of the force of heart contraction(GO:0098735) |
| 0.1 |
0.3 |
GO:0055009 |
atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
| 0.1 |
0.3 |
GO:0036152 |
phosphatidylethanolamine acyl-chain remodeling(GO:0036152) |
| 0.1 |
0.3 |
GO:0046947 |
hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
| 0.1 |
7.7 |
GO:0006501 |
C-terminal protein lipidation(GO:0006501) |
| 0.1 |
0.1 |
GO:0002877 |
acute inflammatory response to non-antigenic stimulus(GO:0002525) regulation of acute inflammatory response to non-antigenic stimulus(GO:0002877) positive regulation of acute inflammatory response to non-antigenic stimulus(GO:0002879) |
| 0.1 |
0.4 |
GO:0030035 |
microspike assembly(GO:0030035) |
| 0.1 |
0.8 |
GO:0034620 |
cellular response to unfolded protein(GO:0034620) |
| 0.1 |
0.4 |
GO:0045047 |
protein targeting to ER(GO:0045047) |
| 0.1 |
0.2 |
GO:0072284 |
metanephric S-shaped body morphogenesis(GO:0072284) |
| 0.1 |
1.0 |
GO:0045663 |
positive regulation of myoblast differentiation(GO:0045663) |
| 0.1 |
0.4 |
GO:0070933 |
histone H4 deacetylation(GO:0070933) |
| 0.1 |
0.2 |
GO:0006478 |
peptidyl-tyrosine sulfation(GO:0006478) |
| 0.1 |
0.2 |
GO:0072249 |
metanephric glomerular epithelium development(GO:0072244) metanephric glomerular visceral epithelial cell differentiation(GO:0072248) metanephric glomerular visceral epithelial cell development(GO:0072249) metanephric glomerular epithelial cell differentiation(GO:0072312) metanephric glomerular epithelial cell development(GO:0072313) |
| 0.1 |
0.4 |
GO:0021904 |
dorsal/ventral neural tube patterning(GO:0021904) |
| 0.1 |
0.2 |
GO:0051758 |
homologous chromosome movement towards spindle pole involved in homologous chromosome segregation(GO:0051758) |
| 0.1 |
0.5 |
GO:1900113 |
negative regulation of histone H3-K9 trimethylation(GO:1900113) |
| 0.1 |
0.2 |
GO:0034146 |
toll-like receptor 5 signaling pathway(GO:0034146) |
| 0.1 |
3.5 |
GO:0032008 |
positive regulation of TOR signaling(GO:0032008) |
| 0.1 |
0.8 |
GO:0002291 |
T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
| 0.1 |
0.1 |
GO:0002448 |
mast cell mediated immunity(GO:0002448) |
| 0.1 |
0.3 |
GO:0006566 |
threonine metabolic process(GO:0006566) |
| 0.1 |
0.2 |
GO:0051963 |
regulation of synapse assembly(GO:0051963) |
| 0.1 |
0.7 |
GO:0070294 |
renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
| 0.1 |
0.1 |
GO:0006581 |
acetylcholine catabolic process in synaptic cleft(GO:0001507) acetylcholine catabolic process(GO:0006581) |
| 0.1 |
0.1 |
GO:0006579 |
amino-acid betaine catabolic process(GO:0006579) |
| 0.1 |
0.1 |
GO:0019285 |
glycine betaine biosynthetic process from choline(GO:0019285) glycine betaine metabolic process(GO:0031455) glycine betaine biosynthetic process(GO:0031456) |
| 0.1 |
0.1 |
GO:0070827 |
chromatin maintenance(GO:0070827) |
| 0.1 |
0.7 |
GO:0035589 |
G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
| 0.1 |
0.4 |
GO:0043380 |
regulation of memory T cell differentiation(GO:0043380) |
| 0.1 |
0.3 |
GO:0071557 |
histone H3-K27 demethylation(GO:0071557) |
| 0.1 |
5.0 |
GO:0006958 |
complement activation, classical pathway(GO:0006958) |
| 0.1 |
1.4 |
GO:0016024 |
CDP-diacylglycerol biosynthetic process(GO:0016024) |
| 0.1 |
0.9 |
GO:0045662 |
negative regulation of myoblast differentiation(GO:0045662) |
| 0.1 |
0.4 |
GO:0006420 |
arginyl-tRNA aminoacylation(GO:0006420) |
| 0.1 |
0.4 |
GO:1901993 |
meiotic cell cycle phase transition(GO:0044771) regulation of meiotic cell cycle phase transition(GO:1901993) |
| 0.1 |
0.8 |
GO:0009312 |
oligosaccharide biosynthetic process(GO:0009312) |
| 0.1 |
0.4 |
GO:0007290 |
spermatid nucleus elongation(GO:0007290) |
| 0.1 |
0.1 |
GO:0010155 |
regulation of proton transport(GO:0010155) |
| 0.1 |
0.1 |
GO:0001560 |
regulation of cell growth by extracellular stimulus(GO:0001560) |
| 0.1 |
0.2 |
GO:0060385 |
axonogenesis involved in innervation(GO:0060385) |
| 0.1 |
0.9 |
GO:0031115 |
negative regulation of microtubule polymerization(GO:0031115) |
| 0.1 |
0.9 |
GO:0044804 |
nucleophagy(GO:0044804) |
| 0.1 |
0.1 |
GO:1902616 |
acyl carnitine transport(GO:0006844) acyl carnitine transmembrane transport(GO:1902616) |
| 0.1 |
0.6 |
GO:0045351 |
type I interferon biosynthetic process(GO:0045351) |
| 0.1 |
0.4 |
GO:1900273 |
positive regulation of long-term synaptic potentiation(GO:1900273) |
| 0.1 |
1.1 |
GO:0015671 |
oxygen transport(GO:0015671) |
| 0.1 |
0.6 |
GO:0044331 |
cell-cell adhesion mediated by cadherin(GO:0044331) |
| 0.1 |
0.1 |
GO:0035494 |
SNARE complex disassembly(GO:0035494) |
| 0.1 |
1.6 |
GO:0090286 |
cytoskeletal anchoring at nuclear membrane(GO:0090286) |
| 0.1 |
1.5 |
GO:0043252 |
sodium-independent organic anion transport(GO:0043252) |
| 0.1 |
0.2 |
GO:0002636 |
positive regulation of germinal center formation(GO:0002636) |
| 0.1 |
0.1 |
GO:0042311 |
vasodilation(GO:0042311) |
| 0.1 |
0.1 |
GO:0045950 |
negative regulation of mitotic recombination(GO:0045950) |
| 0.1 |
0.3 |
GO:0006702 |
androgen biosynthetic process(GO:0006702) progesterone metabolic process(GO:0042448) |
| 0.1 |
0.8 |
GO:0034983 |
peptidyl-lysine deacetylation(GO:0034983) |
| 0.1 |
0.1 |
GO:1901890 |
positive regulation of cell junction assembly(GO:1901890) |
| 0.1 |
0.6 |
GO:0060297 |
regulation of sarcomere organization(GO:0060297) |
| 0.1 |
0.3 |
GO:0014904 |
myotube cell development(GO:0014904) |
| 0.1 |
0.1 |
GO:0051930 |
regulation of sensory perception of pain(GO:0051930) regulation of sensory perception(GO:0051931) |
| 0.1 |
0.5 |
GO:0071712 |
ER-associated misfolded protein catabolic process(GO:0071712) |
| 0.1 |
0.9 |
GO:0003417 |
growth plate cartilage development(GO:0003417) |
| 0.1 |
0.2 |
GO:0014826 |
vein smooth muscle contraction(GO:0014826) |
| 0.1 |
0.2 |
GO:0044829 |
positive regulation by host of viral genome replication(GO:0044829) |
| 0.1 |
4.9 |
GO:0048791 |
calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
| 0.1 |
0.2 |
GO:0048213 |
Golgi vesicle prefusion complex stabilization(GO:0048213) |
| 0.1 |
0.3 |
GO:0098810 |
neurotransmitter reuptake(GO:0098810) |
| 0.1 |
0.2 |
GO:0010800 |
positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
| 0.1 |
0.8 |
GO:0010830 |
regulation of myotube differentiation(GO:0010830) |
| 0.1 |
0.9 |
GO:0038203 |
TORC2 signaling(GO:0038203) |
| 0.1 |
0.2 |
GO:1901535 |
regulation of DNA demethylation(GO:1901535) |
| 0.1 |
1.6 |
GO:0034383 |
low-density lipoprotein particle clearance(GO:0034383) |
| 0.1 |
0.8 |
GO:0006547 |
histidine metabolic process(GO:0006547) |
| 0.1 |
1.0 |
GO:0060044 |
negative regulation of cardiac muscle cell proliferation(GO:0060044) |
| 0.1 |
0.4 |
GO:0010867 |
positive regulation of triglyceride biosynthetic process(GO:0010867) |
| 0.1 |
0.5 |
GO:0097167 |
circadian regulation of translation(GO:0097167) |
| 0.1 |
0.2 |
GO:0061037 |
negative regulation of cartilage development(GO:0061037) |
| 0.1 |
0.3 |
GO:0003416 |
endochondral bone growth(GO:0003416) |
| 0.1 |
0.8 |
GO:0033141 |
positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
| 0.1 |
3.0 |
GO:0015701 |
bicarbonate transport(GO:0015701) |
| 0.1 |
0.3 |
GO:0034729 |
histone H3-K79 methylation(GO:0034729) |
| 0.1 |
0.3 |
GO:0071799 |
response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
| 0.1 |
0.9 |
GO:0060666 |
dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
| 0.1 |
0.1 |
GO:1902626 |
assembly of large subunit precursor of preribosome(GO:1902626) |
| 0.1 |
0.2 |
GO:1904046 |
negative regulation of vascular endothelial growth factor production(GO:1904046) |
| 0.1 |
0.1 |
GO:0002586 |
regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002586) |
| 0.1 |
0.2 |
GO:0070562 |
regulation of vitamin D receptor signaling pathway(GO:0070562) |
| 0.1 |
0.4 |
GO:1904222 |
regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.1 |
1.4 |
GO:0032981 |
NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
| 0.1 |
0.1 |
GO:2000667 |
interleukin-5 secretion(GO:0072603) interleukin-13 secretion(GO:0072611) regulation of interleukin-5 secretion(GO:2000662) positive regulation of interleukin-5 secretion(GO:2000664) regulation of interleukin-13 secretion(GO:2000665) positive regulation of interleukin-13 secretion(GO:2000667) |
| 0.1 |
0.4 |
GO:0098703 |
calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
| 0.1 |
0.5 |
GO:1900745 |
positive regulation of p38MAPK cascade(GO:1900745) |
| 0.1 |
0.1 |
GO:0002025 |
vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
| 0.1 |
0.2 |
GO:0090394 |
negative regulation of excitatory postsynaptic potential(GO:0090394) |
| 0.1 |
2.1 |
GO:0035136 |
forelimb morphogenesis(GO:0035136) |
| 0.1 |
0.3 |
GO:0045141 |
meiotic telomere clustering(GO:0045141) |
| 0.1 |
0.1 |
GO:0032972 |
regulation of muscle filament sliding speed(GO:0032972) |
| 0.1 |
0.2 |
GO:0045872 |
positive regulation of rhodopsin gene expression(GO:0045872) |
| 0.1 |
0.8 |
GO:0061088 |
regulation of sequestering of zinc ion(GO:0061088) |
| 0.1 |
1.4 |
GO:0045879 |
negative regulation of smoothened signaling pathway(GO:0045879) |
| 0.1 |
1.2 |
GO:0000027 |
ribosomal large subunit assembly(GO:0000027) |
| 0.1 |
1.0 |
GO:0015844 |
monoamine transport(GO:0015844) |
| 0.1 |
0.1 |
GO:2000297 |
negative regulation of synapse maturation(GO:2000297) |
| 0.1 |
0.8 |
GO:0048246 |
macrophage chemotaxis(GO:0048246) |
| 0.1 |
0.5 |
GO:0070059 |
intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
| 0.1 |
0.4 |
GO:0016128 |
phytosteroid metabolic process(GO:0016128) phytosteroid biosynthetic process(GO:0016129) |
| 0.1 |
0.4 |
GO:0030730 |
sequestering of triglyceride(GO:0030730) |
| 0.1 |
0.7 |
GO:0007588 |
excretion(GO:0007588) |
| 0.1 |
0.3 |
GO:0030263 |
apoptotic chromosome condensation(GO:0030263) |
| 0.1 |
0.1 |
GO:1902093 |
positive regulation of sperm motility(GO:1902093) |
| 0.1 |
1.2 |
GO:0016254 |
preassembly of GPI anchor in ER membrane(GO:0016254) |
| 0.1 |
2.6 |
GO:0006362 |
transcription elongation from RNA polymerase I promoter(GO:0006362) |
| 0.1 |
0.2 |
GO:0072137 |
condensed mesenchymal cell proliferation(GO:0072137) |
| 0.1 |
0.2 |
GO:0008216 |
spermidine metabolic process(GO:0008216) |
| 0.1 |
0.2 |
GO:0060700 |
regulation of ribonuclease activity(GO:0060700) |
| 0.1 |
1.2 |
GO:0031295 |
lymphocyte costimulation(GO:0031294) T cell costimulation(GO:0031295) |
| 0.1 |
0.4 |
GO:0070072 |
proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
| 0.1 |
0.8 |
GO:0031063 |
regulation of histone deacetylation(GO:0031063) |
| 0.1 |
0.1 |
GO:0097152 |
mesenchymal cell apoptotic process(GO:0097152) |
| 0.1 |
0.5 |
GO:0060314 |
regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
| 0.1 |
0.4 |
GO:0034497 |
protein localization to pre-autophagosomal structure(GO:0034497) |
| 0.1 |
1.3 |
GO:0050908 |
detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
| 0.1 |
0.1 |
GO:0035927 |
RNA import into mitochondrion(GO:0035927) |
| 0.1 |
0.4 |
GO:0030238 |
male sex determination(GO:0030238) |
| 0.1 |
0.3 |
GO:0048642 |
negative regulation of skeletal muscle tissue development(GO:0048642) |
| 0.1 |
0.1 |
GO:2001013 |
epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
| 0.1 |
1.4 |
GO:1902235 |
regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902235) |
| 0.1 |
1.2 |
GO:0006516 |
glycoprotein catabolic process(GO:0006516) |
| 0.0 |
0.6 |
GO:0061577 |
calcium ion transmembrane transport via high voltage-gated calcium channel(GO:0061577) |
| 0.0 |
0.3 |
GO:1902221 |
L-phenylalanine metabolic process(GO:0006558) L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
| 0.0 |
0.1 |
GO:0007341 |
penetration of zona pellucida(GO:0007341) |
| 0.0 |
0.5 |
GO:1903012 |
positive regulation of bone development(GO:1903012) |
| 0.0 |
1.7 |
GO:0019915 |
lipid storage(GO:0019915) |
| 0.0 |
0.9 |
GO:0045947 |
negative regulation of translational initiation(GO:0045947) |
| 0.0 |
0.2 |
GO:0070269 |
pyroptosis(GO:0070269) |
| 0.0 |
0.7 |
GO:0001829 |
trophectodermal cell differentiation(GO:0001829) |
| 0.0 |
0.9 |
GO:0051926 |
negative regulation of calcium ion transport(GO:0051926) |
| 0.0 |
0.4 |
GO:0070574 |
cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
| 0.0 |
0.3 |
GO:0006574 |
valine catabolic process(GO:0006574) |
| 0.0 |
0.2 |
GO:0060080 |
inhibitory postsynaptic potential(GO:0060080) |
| 0.0 |
0.5 |
GO:0070050 |
neuron cellular homeostasis(GO:0070050) |
| 0.0 |
0.1 |
GO:0035092 |
sperm chromatin condensation(GO:0035092) |
| 0.0 |
0.2 |
GO:0016098 |
monoterpenoid metabolic process(GO:0016098) |
| 0.0 |
0.6 |
GO:0007258 |
JUN phosphorylation(GO:0007258) |
| 0.0 |
0.3 |
GO:0006729 |
tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
| 0.0 |
0.5 |
GO:0019800 |
peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 0.0 |
1.5 |
GO:0045746 |
negative regulation of Notch signaling pathway(GO:0045746) |
| 0.0 |
0.0 |
GO:0051683 |
establishment of Golgi localization(GO:0051683) |
| 0.0 |
0.2 |
GO:0060685 |
regulation of prostatic bud formation(GO:0060685) |
| 0.0 |
0.1 |
GO:0060330 |
regulation of response to interferon-gamma(GO:0060330) |
| 0.0 |
0.3 |
GO:1904262 |
negative regulation of TORC1 signaling(GO:1904262) |
| 0.0 |
0.2 |
GO:0035640 |
exploration behavior(GO:0035640) |
| 0.0 |
1.1 |
GO:0046135 |
pyrimidine nucleoside catabolic process(GO:0046135) |
| 0.0 |
0.1 |
GO:1903546 |
protein localization to photoreceptor outer segment(GO:1903546) |
| 0.0 |
0.3 |
GO:0061303 |
cornea development in camera-type eye(GO:0061303) |
| 0.0 |
0.1 |
GO:0005513 |
detection of calcium ion(GO:0005513) |
| 0.0 |
0.2 |
GO:0046689 |
response to mercury ion(GO:0046689) |
| 0.0 |
0.4 |
GO:0035878 |
nail development(GO:0035878) |
| 0.0 |
0.1 |
GO:0046548 |
retinal rod cell development(GO:0046548) |
| 0.0 |
0.5 |
GO:0015695 |
organic cation transport(GO:0015695) |
| 0.0 |
0.7 |
GO:0030150 |
protein import into mitochondrial matrix(GO:0030150) |
| 0.0 |
0.5 |
GO:0035338 |
long-chain fatty-acyl-CoA biosynthetic process(GO:0035338) |
| 0.0 |
0.1 |
GO:1990167 |
protein K27-linked deubiquitination(GO:1990167) |
| 0.0 |
0.2 |
GO:0042373 |
vitamin K metabolic process(GO:0042373) |
| 0.0 |
0.2 |
GO:0038166 |
angiotensin-activated signaling pathway(GO:0038166) |
| 0.0 |
0.1 |
GO:0046056 |
dADP metabolic process(GO:0046056) |
| 0.0 |
0.8 |
GO:0031573 |
intra-S DNA damage checkpoint(GO:0031573) |
| 0.0 |
0.2 |
GO:0002281 |
macrophage activation involved in immune response(GO:0002281) |
| 0.0 |
0.1 |
GO:1990504 |
dense core granule exocytosis(GO:1990504) |
| 0.0 |
0.4 |
GO:0006828 |
manganese ion transport(GO:0006828) |
| 0.0 |
0.7 |
GO:0061049 |
physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.0 |
0.0 |
GO:0006591 |
ornithine metabolic process(GO:0006591) |
| 0.0 |
0.1 |
GO:0008063 |
Toll signaling pathway(GO:0008063) |
| 0.0 |
0.1 |
GO:0048260 |
positive regulation of receptor-mediated endocytosis(GO:0048260) |
| 0.0 |
0.6 |
GO:0090168 |
Golgi reassembly(GO:0090168) |
| 0.0 |
0.1 |
GO:0046338 |
phosphatidylethanolamine catabolic process(GO:0046338) |
| 0.0 |
0.1 |
GO:0035616 |
histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
| 0.0 |
0.1 |
GO:0044362 |
modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
| 0.0 |
0.3 |
GO:0021615 |
glossopharyngeal nerve morphogenesis(GO:0021615) |
| 0.0 |
0.1 |
GO:0035624 |
receptor transactivation(GO:0035624) |
| 0.0 |
1.2 |
GO:0007189 |
adenylate cyclase-activating G-protein coupled receptor signaling pathway(GO:0007189) |
| 0.0 |
0.1 |
GO:0006710 |
androgen catabolic process(GO:0006710) |
| 0.0 |
0.1 |
GO:0036511 |
trimming of terminal mannose on B branch(GO:0036509) trimming of terminal mannose on C branch(GO:0036510) trimming of first mannose on A branch(GO:0036511) trimming of second mannose on A branch(GO:0036512) |
| 0.0 |
0.3 |
GO:0032483 |
regulation of Rab protein signal transduction(GO:0032483) |
| 0.0 |
0.3 |
GO:0014898 |
muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
| 0.0 |
0.2 |
GO:0042255 |
ribosome assembly(GO:0042255) |
| 0.0 |
0.2 |
GO:0051155 |
positive regulation of striated muscle cell differentiation(GO:0051155) |
| 0.0 |
1.2 |
GO:0018279 |
peptidyl-asparagine modification(GO:0018196) protein N-linked glycosylation via asparagine(GO:0018279) |
| 0.0 |
0.4 |
GO:0032785 |
negative regulation of DNA-templated transcription, elongation(GO:0032785) |
| 0.0 |
0.1 |
GO:0048662 |
negative regulation of smooth muscle cell proliferation(GO:0048662) |
| 0.0 |
0.2 |
GO:0007196 |
adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
| 0.0 |
0.5 |
GO:0006685 |
sphingomyelin catabolic process(GO:0006685) |
| 0.0 |
1.2 |
GO:0006487 |
protein N-linked glycosylation(GO:0006487) |
| 0.0 |
0.2 |
GO:0021853 |
cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
| 0.0 |
0.1 |
GO:0007320 |
insemination(GO:0007320) |
| 0.0 |
0.2 |
GO:1904781 |
positive regulation of protein localization to centrosome(GO:1904781) |
| 0.0 |
0.1 |
GO:0061107 |
seminal vesicle development(GO:0061107) |
| 0.0 |
0.2 |
GO:0070649 |
polar body extrusion after meiotic divisions(GO:0040038) formin-nucleated actin cable assembly(GO:0070649) |
| 0.0 |
0.1 |
GO:0032203 |
telomere formation via telomerase(GO:0032203) |
| 0.0 |
0.2 |
GO:0008595 |
tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
| 0.0 |
0.0 |
GO:0007060 |
male meiosis chromosome segregation(GO:0007060) |
| 0.0 |
0.5 |
GO:0060074 |
synapse maturation(GO:0060074) |
| 0.0 |
0.1 |
GO:0050913 |
sensory perception of bitter taste(GO:0050913) |
| 0.0 |
0.1 |
GO:0046900 |
tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
| 0.0 |
0.2 |
GO:0032075 |
positive regulation of nuclease activity(GO:0032075) |
| 0.0 |
0.3 |
GO:0048665 |
neuron fate specification(GO:0048665) |
| 0.0 |
0.2 |
GO:0006432 |
phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 0.0 |
0.1 |
GO:0000212 |
meiotic spindle organization(GO:0000212) |
| 0.0 |
0.1 |
GO:0010796 |
regulation of multivesicular body size(GO:0010796) |
| 0.0 |
0.2 |
GO:0071542 |
dopaminergic neuron differentiation(GO:0071542) |
| 0.0 |
0.1 |
GO:0070296 |
sarcoplasmic reticulum calcium ion transport(GO:0070296) |
| 0.0 |
0.5 |
GO:0010991 |
negative regulation of SMAD protein complex assembly(GO:0010991) |
| 0.0 |
0.1 |
GO:1903215 |
negative regulation of protein targeting to mitochondrion(GO:1903215) |
| 0.0 |
0.2 |
GO:0030214 |
hyaluronan catabolic process(GO:0030214) |
| 0.0 |
0.3 |
GO:0071276 |
cellular response to cadmium ion(GO:0071276) |
| 0.0 |
0.2 |
GO:0016558 |
protein import into peroxisome matrix(GO:0016558) |
| 0.0 |
0.1 |
GO:0030538 |
embryonic genitalia morphogenesis(GO:0030538) |
| 0.0 |
0.4 |
GO:0090200 |
positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
| 0.0 |
0.9 |
GO:0006836 |
neurotransmitter transport(GO:0006836) |
| 0.0 |
0.2 |
GO:0051694 |
pointed-end actin filament capping(GO:0051694) |
| 0.0 |
0.3 |
GO:0050427 |
purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
| 0.0 |
0.2 |
GO:1904694 |
negative regulation of vascular smooth muscle contraction(GO:1904694) |
| 0.0 |
0.3 |
GO:0019933 |
cAMP-mediated signaling(GO:0019933) |
| 0.0 |
0.2 |
GO:0038112 |
interleukin-8-mediated signaling pathway(GO:0038112) |
| 0.0 |
0.2 |
GO:0001865 |
NK T cell differentiation(GO:0001865) |
| 0.0 |
0.5 |
GO:0001675 |
acrosome assembly(GO:0001675) |
| 0.0 |
0.1 |
GO:1903010 |
regulation of bone development(GO:1903010) |
| 0.0 |
0.1 |
GO:0090219 |
negative regulation of lipid kinase activity(GO:0090219) |
| 0.0 |
0.1 |
GO:0006983 |
ER overload response(GO:0006983) |
| 0.0 |
0.4 |
GO:0035082 |
axoneme assembly(GO:0035082) |
| 0.0 |
0.3 |
GO:0016559 |
peroxisome fission(GO:0016559) |
| 0.0 |
0.0 |
GO:0000706 |
meiotic DNA double-strand break processing(GO:0000706) |
| 0.0 |
0.2 |
GO:2000059 |
negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
| 0.0 |
0.1 |
GO:0042136 |
neurotransmitter biosynthetic process(GO:0042136) |
| 0.0 |
0.1 |
GO:0035025 |
positive regulation of Rho protein signal transduction(GO:0035025) |
| 0.0 |
0.1 |
GO:1901078 |
negative regulation of relaxation of muscle(GO:1901078) negative regulation of relaxation of cardiac muscle(GO:1901898) |
| 0.0 |
0.2 |
GO:0070966 |
nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
| 0.0 |
0.1 |
GO:0048566 |
embryonic digestive tract development(GO:0048566) |
| 0.0 |
0.1 |
GO:0033564 |
anterior/posterior axon guidance(GO:0033564) |
| 0.0 |
0.2 |
GO:1904415 |
regulation of xenophagy(GO:1904415) positive regulation of xenophagy(GO:1904417) |
| 0.0 |
1.4 |
GO:0060337 |
type I interferon signaling pathway(GO:0060337) cellular response to type I interferon(GO:0071357) |
| 0.0 |
0.1 |
GO:0018214 |
peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
| 0.0 |
0.0 |
GO:0007342 |
fusion of sperm to egg plasma membrane(GO:0007342) |
| 0.0 |
0.1 |
GO:0045776 |
negative regulation of blood pressure(GO:0045776) |
| 0.0 |
0.2 |
GO:0050832 |
defense response to fungus(GO:0050832) |
| 0.0 |
0.2 |
GO:0043981 |
histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
| 0.0 |
0.3 |
GO:0044364 |
killing of cells of other organism(GO:0031640) disruption of cells of other organism(GO:0044364) |
| 0.0 |
0.3 |
GO:0048713 |
regulation of oligodendrocyte differentiation(GO:0048713) |
| 0.0 |
0.1 |
GO:0033563 |
dorsal/ventral axon guidance(GO:0033563) |
| 0.0 |
0.3 |
GO:0034587 |
piRNA metabolic process(GO:0034587) |
| 0.0 |
0.2 |
GO:0032020 |
ISG15-protein conjugation(GO:0032020) |
| 0.0 |
0.3 |
GO:0036315 |
cellular response to sterol(GO:0036315) |
| 0.0 |
0.4 |
GO:0006030 |
chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
| 0.0 |
0.1 |
GO:0016127 |
cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
| 0.0 |
0.2 |
GO:0070493 |
thrombin receptor signaling pathway(GO:0070493) |
| 0.0 |
0.1 |
GO:0035278 |
miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
| 0.0 |
0.1 |
GO:2000346 |
negative regulation of hepatocyte proliferation(GO:2000346) |
| 0.0 |
0.5 |
GO:0043484 |
regulation of RNA splicing(GO:0043484) |
| 0.0 |
0.2 |
GO:0050829 |
defense response to Gram-negative bacterium(GO:0050829) |
| 0.0 |
0.0 |
GO:0060748 |
tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
| 0.0 |
0.0 |
GO:1900121 |
negative regulation of receptor binding(GO:1900121) |
| 0.0 |
0.1 |
GO:0098780 |
response to mitochondrial depolarisation(GO:0098780) |
| 0.0 |
0.1 |
GO:0032185 |
septin cytoskeleton organization(GO:0032185) |
| 0.0 |
0.1 |
GO:0090131 |
mesenchyme migration(GO:0090131) |
| 0.0 |
0.1 |
GO:0034427 |
nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
| 0.0 |
0.0 |
GO:0051387 |
negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
| 0.0 |
0.0 |
GO:0060290 |
transdifferentiation(GO:0060290) |
| 0.0 |
0.1 |
GO:0002572 |
pro-T cell differentiation(GO:0002572) regulation of pro-T cell differentiation(GO:2000174) positive regulation of pro-T cell differentiation(GO:2000176) |
| 0.0 |
0.2 |
GO:0035855 |
megakaryocyte development(GO:0035855) |
| 0.0 |
0.1 |
GO:0016525 |
negative regulation of angiogenesis(GO:0016525) |
| 0.0 |
0.4 |
GO:0035729 |
cellular response to hepatocyte growth factor stimulus(GO:0035729) |
| 0.0 |
0.0 |
GO:1902232 |
regulation of positive thymic T cell selection(GO:1902232) |
| 0.0 |
0.1 |
GO:0036151 |
phosphatidylcholine acyl-chain remodeling(GO:0036151) |
| 0.0 |
0.0 |
GO:1901881 |
positive regulation of protein depolymerization(GO:1901881) |
| 0.0 |
0.1 |
GO:0035021 |
negative regulation of Rac protein signal transduction(GO:0035021) |
| 0.0 |
0.2 |
GO:0035360 |
positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
| 0.0 |
0.1 |
GO:0040016 |
embryonic cleavage(GO:0040016) |
| 0.0 |
0.2 |
GO:0070207 |
protein homotrimerization(GO:0070207) |
| 0.0 |
0.8 |
GO:0071347 |
cellular response to interleukin-1(GO:0071347) |
| 0.0 |
0.0 |
GO:0046603 |
negative regulation of mitotic centrosome separation(GO:0046603) |
| 0.0 |
0.1 |
GO:0034638 |
phosphatidylcholine catabolic process(GO:0034638) |
| 0.0 |
0.2 |
GO:0007271 |
synaptic transmission, cholinergic(GO:0007271) |
| 0.0 |
0.0 |
GO:1900227 |
positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
| 0.0 |
0.0 |
GO:0046085 |
adenosine metabolic process(GO:0046085) |
| 0.0 |
0.1 |
GO:0070934 |
CRD-mediated mRNA stabilization(GO:0070934) |
| 0.0 |
0.1 |
GO:0032484 |
Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
| 0.0 |
0.1 |
GO:0035542 |
regulation of SNARE complex assembly(GO:0035542) |
| 0.0 |
0.1 |
GO:0035511 |
oxidative DNA demethylation(GO:0035511) |
| 0.0 |
0.0 |
GO:0033386 |
geranylgeranyl diphosphate metabolic process(GO:0033385) geranylgeranyl diphosphate biosynthetic process(GO:0033386) |
